Clinical Trials

Metformin is evaluated across numerous clinical trials investigating metabolic, inflammatory, and post-viral indications, including type 2 diabetes, gestational diabetes, polycystic ovary syndrome, pulmonary sarcoidosis, and Long COVID. Spanning Early Phase 1 through Phase 4, these studies are supported by academic institutions, medical centers, and pharmaceutical sponsors, such as the University of Maryland, Fudan University, and Boehringer Ingelheim. Trial statuses currently range from completed bioequivalence evaluations to active recruitment and newly planned studies.

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07724132 RECRUITING
Alzheimer's Disease (AD); Mild Cognitive Impairment Due to Alzheimer's Disease; Alzheimer Disease Dementia
University College, London
 2026-07-24 PHASE3
NCT07724132 RECRUITING
Alzheimer's Disease (AD); Mild Cognitive Impairment Due to Alzheimer's Disease; Alzheimer Disease Dementia
University College, London
 2026-07-24 PHASE3
NCT01042379 RECRUITING
Breast Neoplasms; Breast Cancer; Breast Tumors; Angiosarcoma; TNBC - Triple-Negative Breast Cancer; HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer
QuantumLeap Healthcare Collaborative
 2010-03-01 PHASE2
NCT01042379 RECRUITING
Breast Neoplasms; Breast Cancer; Breast Tumors; Angiosarcoma; TNBC - Triple-Negative Breast Cancer; HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer
QuantumLeap Healthcare Collaborative
 2010-03-01 PHASE2
NCT06185179 RECRUITING
Muscle Atrophy or Weakness
University of Utah
 2024-09-01 EARLY_PHASE1
NCT06185179 RECRUITING
Muscle Atrophy or Weakness
University of Utah
 2024-09-01 EARLY_PHASE1
NCT06246799 RECRUITING
Type 2 Diabetes (Adult Onset)
The University of Texas Health Science Center at San Antonio
 2024-11-07 PHASE3
NCT06246799 RECRUITING
Type 2 Diabetes (Adult Onset)
The University of Texas Health Science Center at San Antonio
 2024-11-07 PHASE3
NCT07342764 NOT_YET_RECRUITING
Antipsychotic-induced Weight Gain (AIWG); Antipsychotic-induced Weight Gain
Sultan Qaboos University
 2026-09 PHASE4
NCT07342764 NOT_YET_RECRUITING
Antipsychotic-induced Weight Gain (AIWG); Antipsychotic-induced Weight Gain
Sultan Qaboos University
 2026-09 PHASE4
NCT04500756 RECRUITING
Abdominal Aortic Aneurysm
Stanford University
 2022-02-28 PHASE2
NCT04500756 RECRUITING
Abdominal Aortic Aneurysm
Stanford University
 2022-02-28 PHASE2
NCT07057479 WITHDRAWN
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
 2026-09 PHASE3
NCT07057479 WITHDRAWN
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
 2026-09 PHASE3
NCT07460336 NOT_YET_RECRUITING
Latent Autoimmune Diabetes in Adults (LADA)
Second Xiangya Hospital of Central South University
 2026-05-15
NCT07460336 NOT_YET_RECRUITING
Latent Autoimmune Diabetes in Adults (LADA)
Second Xiangya Hospital of Central South University
 2026-05-15
NCT07280572 ENROLLING_BY_INVITATION
Post COVID Condition
Janneke van de Wijgert
 2025-02-17 PHASE3
NCT07280572 ENROLLING_BY_INVITATION
Post COVID Condition
Janneke van de Wijgert
 2025-02-17 PHASE3
NCT06044025 RECRUITING
Castration Sensitive Prostate Cancer
University of Arkansas
 2024-04-11 PHASE1
NCT06044025 RECRUITING
Castration Sensitive Prostate Cancer
University of Arkansas
 2024-04-11 PHASE1
NCT07645001 RECRUITING
Gestational Diabetes
Riphah International University
 2026-07-29
NCT07645001 RECRUITING
Gestational Diabetes
Riphah International University
 2026-07-29
NCT06560333 WITHDRAWN
Diabetes Mellitus, Type 2
Eurofarma Laboratorios S.A.
 2026-11-30 PHASE3
NCT06560333 WITHDRAWN
Diabetes Mellitus, Type 2
Eurofarma Laboratorios S.A.
 2026-11-30 PHASE3
NCT07293325 RECRUITING
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2025-06-02
NCT07293325 RECRUITING
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
 2025-06-02
NCT06687265 RECRUITING
Cirrhosis; Portal Hypertension Related to Cirrhosis
Assistance Publique - Hôpitaux de Paris
 2025-03-10 PHASE2
NCT06687265 RECRUITING
Cirrhosis; Portal Hypertension Related to Cirrhosis
Assistance Publique - Hôpitaux de Paris
 2025-03-10 PHASE2
NCT07497568 RECRUITING
Dental Implant; Stability
University of Baghdad
 2025-11-01
NCT07497568 RECRUITING
Dental Implant; Stability
University of Baghdad
 2025-11-01
NCT05893225 ACTIVE_NOT_RECRUITING
Multiple Sclerosis; Primary Progressive Multiple Sclerosis; Secondary-progressive Multiple Sclerosis
University Hospital, Antwerp
 2023-11-23 PHASE2
NCT05893225 ACTIVE_NOT_RECRUITING
Multiple Sclerosis; Primary Progressive Multiple Sclerosis; Secondary-progressive Multiple Sclerosis
University Hospital, Antwerp
 2023-11-23 PHASE2
NCT05205317 RECRUITING
Defect
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
 2023-04-15
NCT05205317 RECRUITING
Defect
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
 2023-04-15
NCT06611501 ACTIVE_NOT_RECRUITING
Pelvic Pain; Endometriosis
Boston Children's Hospital
 2025-05-22 PHASE2
NCT06611501 ACTIVE_NOT_RECRUITING
Pelvic Pain; Endometriosis
Boston Children's Hospital
 2025-05-22 PHASE2
NCT06959784 ENROLLING_BY_INVITATION
Diabetes Mellitus; Cardiovascular Diseases; Cerebrovascular Disease
China-Japan Friendship Hospital
 2024-01-01 PHASE4
NCT06959784 ENROLLING_BY_INVITATION
Diabetes Mellitus; Cardiovascular Diseases; Cerebrovascular Disease
China-Japan Friendship Hospital
 2024-01-01 PHASE4
NCT06424860 RECRUITING
PCOS; Cardiovascular Disease; Atherosclerotic Cardiovascular Disease; Atherosclerotic Plaque; Cardiac Hypertrophy
University of Alberta
 2025-11-01 PHASE1
NCT06424860 RECRUITING
PCOS; Cardiovascular Disease; Atherosclerotic Cardiovascular Disease; Atherosclerotic Plaque; Cardiac Hypertrophy
University of Alberta
 2025-11-01 PHASE1
NCT05574387 RECRUITING
Inflammatory Bowel Diseases
Tanta University
 2023-01-20 PHASE2
NCT02969798 RECRUITING
Diabetes Mellitus, Type 2; Impaired Glucose Tolerance (IGT); Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio
 2014-01-01
NCT07487103 NOT_YET_RECRUITING
Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd.
 2026-05-01 PHASE3
NCT07785934 RECRUITING
Drug Drug Interaction (DDI); Pharmacokinetics and Pharmacodynamics
The United Bio-Technology (Hengqin) Co., Ltd.
 2026-05-27 PHASE1
NCT05574387 RECRUITING
Inflammatory Bowel Diseases
Tanta University
 2023-01-20 PHASE2
NCT02969798 RECRUITING
Diabetes Mellitus, Type 2; Impaired Glucose Tolerance (IGT); Impaired Fasting Glucose (IFG)
The University of Texas Health Science Center at San Antonio
 2014-01-01
NCT07785934 RECRUITING
Drug Drug Interaction (DDI); Pharmacokinetics and Pharmacodynamics
The United Bio-Technology (Hengqin) Co., Ltd.
 2026-05-27 PHASE1
NCT07487103 NOT_YET_RECRUITING
Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd.
 2026-05-01 PHASE3
NCT03107884 ACTIVE_NOT_RECRUITING
Muscle Atrophy; Insulin Resistance
University of Utah
 2019-08-01 EARLY_PHASE1
NCT03107884 ACTIVE_NOT_RECRUITING
Muscle Atrophy; Insulin Resistance
University of Utah
 2019-08-01 EARLY_PHASE1
NCT06273072 RECRUITING
Asthma; Asthma Chronic; Overweight and Obesity
Johns Hopkins University
 2024-12-09 PHASE2
NCT06273072 RECRUITING
Asthma; Asthma Chronic; Overweight and Obesity
Johns Hopkins University
 2024-12-09 PHASE2
NCT04194424 ACTIVE_NOT_RECRUITING
Obesity; Weight Loss
American University of Beirut Medical Center
 2023-08-15
NCT04194424 ACTIVE_NOT_RECRUITING
Obesity; Weight Loss
American University of Beirut Medical Center
 2023-08-15
NCT04578652 RECRUITING
Obesity, Childhood; Insulin Resistance
University of Alberta
 2021-10-22 PHASE3
NCT04578652 RECRUITING
Obesity, Childhood; Insulin Resistance
University of Alberta
 2021-10-22 PHASE3
NCT07300046 NOT_YET_RECRUITING
Healthy Volunteers
Aspargo Labs, Inc
 2026-06-15 PHASE1
NCT07300046 NOT_YET_RECRUITING
Healthy Volunteers
Aspargo Labs, Inc
 2026-06-15 PHASE1
NCT07064486 RECRUITING
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
 2025-07-04 PHASE3
NCT07064486 RECRUITING
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
 2025-07-04 PHASE3
NCT07083401 RECRUITING
Diabete Mellitus
Boryung Pharmaceutical Co., Ltd
 2025-07-05 PHASE1
NCT07083401 RECRUITING
Diabete Mellitus
Boryung Pharmaceutical Co., Ltd
 2025-07-05 PHASE1
NCT05345327 RECRUITING
Type 2 Diabetes
The George Institute
 2023-01-01 PHASE3
NCT06851962 COMPLETED
Diabetes Mellitus Type 2
Fundación para la Investigación del Hospital Clínico de Valencia
 2025-05-26 PHASE4
NCT07570082 COMPLETED
Healthy Volunteers
Crinetics Pharmaceuticals Inc.
 2026-05-28 PHASE1
NCT05345327 RECRUITING
Type 2 Diabetes
The George Institute
 2023-01-01 PHASE3
NCT07570082 COMPLETED
Healthy Volunteers
Crinetics Pharmaceuticals Inc.
 2026-05-28 PHASE1
NCT06851962 COMPLETED
Diabetes Mellitus Type 2
Fundación para la Investigación del Hospital Clínico de Valencia
 2025-05-26 PHASE4
NCT07412015 NOT_YET_RECRUITING
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd.
 2026-05-27
NCT07412015 NOT_YET_RECRUITING
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd.
 2026-05-27
NCT06545526 UNKNOWN
Familial Adenomatous Polyposis
Yonsei University
 2024-08-13 PHASE3
NCT06545526 UNKNOWN
Familial Adenomatous Polyposis
Yonsei University
 2024-08-13 PHASE3
NCT07691203 COMPLETED
Type 2 Diabetes Mellitus (T2DM); Cardiovascular Diseases
Humanis Saglık Anonim Sirketi
 2026-03-07 PHASE1
NCT07691203 COMPLETED
Type 2 Diabetes Mellitus (T2DM); Cardiovascular Diseases
Humanis Saglık Anonim Sirketi
 2026-03-07 PHASE1
NCT07436182 NOT_YET_RECRUITING
Mitochondria; Metformin
Mansoura University
 2026-03-01 PHASE4
NCT07436182 NOT_YET_RECRUITING
Mitochondria; Metformin
Mansoura University
 2026-03-01 PHASE4
NCT06589765 COMPLETED
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd.
 2024-09-27 PHASE3
NCT06589765 COMPLETED
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd.
 2024-09-27 PHASE3
NCT07395895 NOT_YET_RECRUITING
Osteoarthritis in Postmenopausal Women
Badr University
 2026-03-01 PHASE3
NCT07395895 NOT_YET_RECRUITING
Osteoarthritis in Postmenopausal Women
Badr University
 2026-03-01 PHASE3
NCT06405178 COMPLETED
Polycystic Ovary
Beni-Suef University
 2026-03-30 PHASE3
NCT06405178 COMPLETED
Polycystic Ovary
Beni-Suef University
 2026-03-30 PHASE3
NCT06716216 RECRUITING
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
 2024-11-29 PHASE3
NCT06716216 RECRUITING
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.
 2024-11-29 PHASE3
NCT07368569 COMPLETED
Healthy
Boehringer Ingelheim
 2026-02-06 PHASE1
NCT07368569 COMPLETED
Healthy
Boehringer Ingelheim
 2026-02-06 PHASE1
NCT06606886 COMPLETED
Transfusion Dependent Beta-thalassemia
Bahria University
 2024-09-16 PHASE4
NCT06606886 COMPLETED
Transfusion Dependent Beta-thalassemia
Bahria University
 2024-09-16 PHASE4
NCT06605703 COMPLETED
Obesity; Overweight
WW International Inc
 2024-09-18 PHASE4
NCT06605703 COMPLETED
Obesity; Overweight
WW International Inc
 2024-09-18 PHASE4
NCT06899061 ACTIVE_NOT_RECRUITING
Advanced Solid Malignancies
AstraZeneca
 2025-03-25 PHASE1
NCT06235086 COMPLETED
Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
 2024-04-08 PHASE3
NCT06899061 ACTIVE_NOT_RECRUITING
Advanced Solid Malignancies
AstraZeneca
 2025-03-25 PHASE1
NCT06235086 COMPLETED
Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
 2024-04-08 PHASE3
NCT07793838 COMPLETED
Polycystic Ovary Syndrome (PCOS) Women
Jerash Private University
 2025-08-01 PHASE4
NCT06836128 RECRUITING
Polycystic Ovary Syndrome
Cairo University
 2025-03-01 PHASE3
NCT07793838 COMPLETED
Polycystic Ovary Syndrome (PCOS) Women
Jerash Private University
 2025-08-01 PHASE4
NCT06836128 RECRUITING
Polycystic Ovary Syndrome
Cairo University
 2025-03-01 PHASE3
NCT07109700 RECRUITING
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
 2025-04-30 PHASE2
NCT07109700 RECRUITING
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
 2025-04-30 PHASE2
NCT04742751 ACTIVE_NOT_RECRUITING
PreDiabetes; Adult Children
St. Jude Children's Research Hospital
 2022-03-02 PHASE2
NCT04742751 ACTIVE_NOT_RECRUITING
PreDiabetes; Adult Children
St. Jude Children's Research Hospital
 2022-03-02 PHASE2
NCT04224051 UNKNOWN
Abdominal Aortic Aneurysm
Uppsala University Hospital
 2020-02-12 PHASE2
NCT04224051 UNKNOWN
Abdominal Aortic Aneurysm
Uppsala University Hospital
 2020-02-12 PHASE2
NCT06589141 UNKNOWN
Gestational Diabetes Mellitus in Pregnancy
Assiut University
 2025-01-01
NCT06589141 UNKNOWN
Gestational Diabetes Mellitus in Pregnancy
Assiut University
 2025-01-01
NCT05093959 COMPLETED
Heart Failure With Preserved Ejection Fraction
Wake Forest University Health Sciences
 2022-01-04 PHASE2
NCT05093959 COMPLETED
Heart Failure With Preserved Ejection Fraction
Wake Forest University Health Sciences
 2022-01-04 PHASE2
NCT06526494 WITHDRAWN
PreDiabetes
Diana Jalal
 2024-11-13 PHASE2
NCT06526494 WITHDRAWN
PreDiabetes
Diana Jalal
 2024-11-13 PHASE2
NCT07333742 COMPLETED
Fed Conditions; Healthy Volunteer
LG Chem
 2025-09-29 PHASE1
NCT07333742 COMPLETED
Fed Conditions; Healthy Volunteer
LG Chem
 2025-09-29 PHASE1
NCT07108075 RECRUITING
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India
 2025-06-14
NCT05469659 RECRUITING
T2DM (Type 2 Diabetes Mellitus); Metformin; SGLT2-Inhibitors
Shinshu University
 2021-09-22 PHASE2
NCT07108075 RECRUITING
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India
 2025-06-14
NCT05469659 RECRUITING
T2DM (Type 2 Diabetes Mellitus); Metformin; SGLT2-Inhibitors
Shinshu University
 2021-09-22 PHASE2
NCT07266779 COMPLETED
Type 2 Diabetes
Humanis Saglık Anonim Sirketi
 2025-08-22 PHASE1
NCT07266779 COMPLETED
Type 2 Diabetes
Humanis Saglık Anonim Sirketi
 2025-08-22 PHASE1
NCT05833958 WITHDRAWN
Type 2 Diabetes
George Medicines PTY Limited
 2024-09 PHASE2
NCT05833958 WITHDRAWN
Type 2 Diabetes
George Medicines PTY Limited
 2024-09 PHASE2
NCT05988684 COMPLETED
PsA (Psoriatic Arthritis)
Chinese University of Hong Kong
 2023-08-30 PHASE4
NCT05988684 COMPLETED
PsA (Psoriatic Arthritis)
Chinese University of Hong Kong
 2023-08-30 PHASE4
NCT06439758 UNKNOWN
Diabetes Type 2; Osteoporosis
King Saud University
 2024-08-01 PHASE4
NCT06439758 UNKNOWN
Diabetes Type 2; Osteoporosis
King Saud University
 2024-08-01 PHASE4
NCT04221750 COMPLETED
Frailty; Sarcopenic Obesity; Aging
VA Office of Research and Development
 2021-05-14 PHASE3
NCT04221750 COMPLETED
Frailty; Sarcopenic Obesity; Aging
VA Office of Research and Development
 2021-05-14 PHASE3
NCT07751549 COMPLETED
Acanthosis Nigricans
Tanta University
 2023-06-03
NCT07751549 COMPLETED
Acanthosis Nigricans
Tanta University
 2023-06-03
NCT07055958 ACTIVE_NOT_RECRUITING
Parkinson Disease
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
 2024-12-29 PHASE3
NCT06327815 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
AstraZeneca
 2024-03-15 PHASE4
NCT07055958 ACTIVE_NOT_RECRUITING
Parkinson Disease
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
 2024-12-29 PHASE3
NCT06327815 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
AstraZeneca
 2024-03-15 PHASE4
NCT02647827 RECRUITING
Polycystic Ovary Syndrome; Insulin Resistance; Hyperandrogenism
Karolinska Institutet
 2015-12 PHASE2
NCT02647827 RECRUITING
Polycystic Ovary Syndrome; Insulin Resistance; Hyperandrogenism
Karolinska Institutet
 2015-12 PHASE2
NCT06481085 COMPLETED
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
 2024-06-27 PHASE2
NCT06481085 COMPLETED
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
 2024-06-27 PHASE2
NCT07387679 COMPLETED
Polycystic Ovarian Syndrome
Muhammad Aamir Latif
 2024-11-29
NCT07387679 COMPLETED
Polycystic Ovarian Syndrome
Muhammad Aamir Latif
 2024-11-29
NCT06845540 RECRUITING
Melasma
University of Puerto Rico
 2025-02-20 PHASE1; PHASE2
NCT06845540 RECRUITING
Melasma
University of Puerto Rico
 2025-02-20 PHASE1; PHASE2
NCT06359015 TERMINATED
Preeclampsia Severe; Pre-Eclampsia; Preeclampsia; Preeclampsia Second Trimester; Preeclampsia Complicating Childbirth; Preeclampsia Puerperium; Preterm
Christiana Care Health Services
 2021-02-11 PHASE4
NCT06359015 TERMINATED
Preeclampsia Severe; Pre-Eclampsia; Preeclampsia; Preeclampsia Second Trimester; Preeclampsia Complicating Childbirth; Preeclampsia Puerperium; Preterm
Christiana Care Health Services
 2021-02-11 PHASE4
NCT04029480 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2019-10-08 PHASE3
NCT04029480 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2019-10-08 PHASE3
NCT07633028 COMPLETED
Bioequivalence Study in Healthy Subjects
ADIUM
 2025-02-10
NCT07633028 COMPLETED
Bioequivalence Study in Healthy Subjects
ADIUM
 2025-02-10
NCT06670209 NOT_YET_RECRUITING
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA
 2024-10-30 PHASE1
NCT06670209 NOT_YET_RECRUITING
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA
 2024-10-30 PHASE1
NCT06860841 ACTIVE_NOT_RECRUITING
Type 2 Diabetes; Overweight and Obese Adults
Campus Bio-Medico University
 2025-01-10 PHASE4
NCT06860841 ACTIVE_NOT_RECRUITING
Type 2 Diabetes; Overweight and Obese Adults
Campus Bio-Medico University
 2025-01-10 PHASE4
NCT01430351 TERMINATED
Glioblastoma; Gliosarcoma; Supratentorial Glioblastoma
M.D. Anderson Cancer Center
 2011-09-14 PHASE1
NCT01430351 TERMINATED
Glioblastoma; Gliosarcoma; Supratentorial Glioblastoma
M.D. Anderson Cancer Center
 2011-09-14 PHASE1
NCT05759312 UNKNOWN
Ovarian Clear Cell Carcinoma
Fudan University
 2023-03 PHASE1; PHASE2
NCT05759312 UNKNOWN
Ovarian Clear Cell Carcinoma
Fudan University
 2023-03 PHASE1; PHASE2
NCT06576375 UNKNOWN
Polycystic Ovary Syndrome
Future University in Egypt
 2024-09-02 PHASE3
NCT06576375 UNKNOWN
Polycystic Ovary Syndrome
Future University in Egypt
 2024-09-02 PHASE3
NCT05034029 UNKNOWN
Osteoarthritis
Guangzhou First People's Hospital
 2021-08-01
NCT05232994 UNKNOWN
Preeclampsia Severe; Preeclampsia Second Trimester; Preterm Birth Complication
Christiana Care Health Services
 2023-03-01 PHASE1
NCT05232994 UNKNOWN
Preeclampsia Severe; Preeclampsia Second Trimester; Preterm Birth Complication
Christiana Care Health Services
 2023-03-01 PHASE1
NCT05034029 UNKNOWN
Osteoarthritis
Guangzhou First People's Hospital
 2021-08-01
NCT04196868 COMPLETED
Arthritis, Rheumatoid
University Hospital, Bordeaux
 2020-12-03 PHASE2
NCT04196868 COMPLETED
Arthritis, Rheumatoid
University Hospital, Bordeaux
 2020-12-03 PHASE2
NCT06353347 COMPLETED
Type 2 Diabetes Mellitus
Shenzhen HighTide Biopharmaceutical Ltd.
 2023-11-13 PHASE3
NCT06353347 COMPLETED
Type 2 Diabetes Mellitus
Shenzhen HighTide Biopharmaceutical Ltd.
 2023-11-13 PHASE3
NCT06147050 UNKNOWN
Long COVID
Purpose Life Sciences
 2024-04 PHASE3
NCT06147050 UNKNOWN
Long COVID
Purpose Life Sciences
 2024-04 PHASE3
NCT04271189 COMPLETED
Newly Diagnosed Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma
 2020-09-01 PHASE3
NCT04271189 COMPLETED
Newly Diagnosed Type 2 Diabetes
Azienda Ospedaliero-Universitaria di Parma
 2020-09-01 PHASE3
NCT04220021 ACTIVE_NOT_RECRUITING
C9orf72 Amyotrophic Lateral Sclerosis (ALS); Frontotemporal Dementia
University of Florida
 2020-01-10 PHASE2
NCT04220021 ACTIVE_NOT_RECRUITING
C9orf72 Amyotrophic Lateral Sclerosis (ALS); Frontotemporal Dementia
University of Florida
 2020-01-10 PHASE2
NCT07077525 COMPLETED
Type 2 Diabetes
Al-Azhar University
 2023-06-01 PHASE4
NCT07077525 COMPLETED
Type 2 Diabetes
Al-Azhar University
 2023-06-01 PHASE4
NCT05979038 UNKNOWN
Sepsis
German University in Cairo
 2023-09-10 PHASE3
NCT03974139 UNKNOWN
Obesity Without Type 2 Diabetes, With BMI>30
Lille Catholic University
 2020-07-03 PHASE2
NCT05979038 UNKNOWN
Sepsis
German University in Cairo
 2023-09-10 PHASE3
NCT03974139 UNKNOWN
Obesity Without Type 2 Diabetes, With BMI>30
Lille Catholic University
 2020-07-03 PHASE2
NCT04275713 COMPLETED
Cervical Cancer
Oslo University Hospital
 2020-05-22 PHASE2
NCT04275713 COMPLETED
Cervical Cancer
Oslo University Hospital
 2020-05-22 PHASE2
NCT06042855 COMPLETED
Covid19
Susanna Naggie, MD
 2023-09-05 PHASE3
NCT06042855 COMPLETED
Covid19
Susanna Naggie, MD
 2023-09-05 PHASE3
NCT05545800 UNKNOWN
Type 2 Diabetes Mellitus
Xiangya Hospital of Central South University
 2022-09-01 PHASE3
NCT06199544 UNKNOWN
Comparative Study
Hamdard University
 2022-10-01 PHASE1
NCT05545800 UNKNOWN
Type 2 Diabetes Mellitus
Xiangya Hospital of Central South University
 2022-09-01 PHASE3
NCT06199544 UNKNOWN
Comparative Study
Hamdard University
 2022-10-01 PHASE1
NCT05906563 UNKNOWN
Bone Loss in Jaw
Amira ragab
 2022-12-14 PHASE2
NCT05910554 Not yet recruiting
Sarcoidosis Pulmonary
University of Maryland Baltimore
 2024-05-01 Phase 2
NCT05906563 UNKNOWN
Bone Loss in Jaw
Amira ragab
 2022-12-14 PHASE2
NCT06247748 COMPLETED
Diabetes Mellitus, Type 2; Overweight
Beijing Dongfang Biotech Co., Ltd.
 2023-10-19 PHASE1
NCT06247748 COMPLETED
Diabetes Mellitus, Type 2; Overweight
Beijing Dongfang Biotech Co., Ltd.
 2023-10-19 PHASE1
NCT05762471 COMPLETED
Overweight or Obesity; Type2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
 2023-01-09 PHASE1; PHASE2
NCT05762471 COMPLETED
Overweight or Obesity; Type2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
 2023-01-09 PHASE1; PHASE2
NCT05373680 COMPLETED
Renal Insufficiency, Chronic
Tanta University
 2022-01-01 PHASE2; PHASE3
NCT05373680 COMPLETED
Renal Insufficiency, Chronic
Tanta University
 2022-01-01 PHASE2; PHASE3
NCT06120881 Recruiting
Type 2 Diabetes
University of California San Francisco|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 2024-04-01 Early Phase 1
NCT06147050 Not yet recruiting
Long COVID
Purpose Life Sciences
 2024-04 Phase 3
NCT06296836 Not yet recruiting
Diabetes Mellitus Type 2
University of Illinois at Chicago|Emily Hanners|Dulal Bhaumik|Avisek Datta|Peggy Choye|Hailey Soni|Annesti Elmasri|Julie Jun|Colin Goodman
 2024-04-01 Phase 4
NCT04841096 COMPLETED
Type 2 Diabetes
Laboratorios Silanes S.A. de C.V.
 2023-03-21 PHASE3
NCT04841096 COMPLETED
Type 2 Diabetes
Laboratorios Silanes S.A. de C.V.
 2023-03-21 PHASE3
NCT01864096 UNKNOWN
Prostate Cancer
University Health Network, Toronto
 2013-10 PHASE3
NCT01864096 UNKNOWN
Prostate Cancer
University Health Network, Toronto
 2013-10 PHASE3
NCT07437612 COMPLETED
Periapical Periodontitis, Chronic Nonsuppurative
Celalettin Topbaş
 2023-02-13 PHASE2
NCT07437612 COMPLETED
Periapical Periodontitis, Chronic Nonsuppurative
Celalettin Topbaş
 2023-02-13 PHASE2
NCT04984070 UNKNOWN
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries; Depression, Anxiety
Fudan University
 2021-01-01
NCT04984070 UNKNOWN
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries; Depression, Anxiety
Fudan University
 2021-01-01
NCT05262257 UNKNOWN
Type2 Diabetes
The First Affiliated Hospital with Nanjing Medical University
 2022-04-01 EARLY_PHASE1
NCT05653895 COMPLETED
PCOS
Khyber Medical University Peshawar
 2022-12-07
NCT05262257 UNKNOWN
Type2 Diabetes
The First Affiliated Hospital with Nanjing Medical University
 2022-04-01 EARLY_PHASE1
NCT05653895 COMPLETED
PCOS
Khyber Medical University Peshawar
 2022-12-07
NCT07076056 COMPLETED
Type 2 Diabetes
Daewon Pharmaceutical Co., Ltd.
 2022-10-27 PHASE3
NCT07076056 COMPLETED
Type 2 Diabetes
Daewon Pharmaceutical Co., Ltd.
 2022-10-27 PHASE3
NCT05688332 UNKNOWN
Diabetes Mellitus Type 2 Without Complication
University of Zambia
 2023-08 PHASE3
NCT05688332 UNKNOWN
Diabetes Mellitus Type 2 Without Complication
University of Zambia
 2023-08 PHASE3
NCT05504226 COMPLETED
Type 2 Diabetes
Handok Inc.
 2022-10-12 PHASE3
NCT05504226 COMPLETED
Type 2 Diabetes
Handok Inc.
 2022-10-12 PHASE3
NCT05994586 UNKNOWN
Diabetes in Adolescence; PreDiabetes
AronPharma Sp. z o. o.
 2023-05-25
NCT05994586 UNKNOWN
Diabetes in Adolescence; PreDiabetes
AronPharma Sp. z o. o.
 2023-05-25
NCT01905046 ACTIVE_NOT_RECRUITING
Atypical Ductal Breast Hyperplasia; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ
Alliance for Clinical Trials in Oncology
 2015-11-23 PHASE3
NCT05965219 COMPLETED
Healthy Volunteers
Cerevel Therapeutics, LLC
 2023-08-15 PHASE1
NCT01905046 ACTIVE_NOT_RECRUITING
Atypical Ductal Breast Hyperplasia; BRCA1 Mutation Carrier; BRCA2 Mutation Carrier; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ
Alliance for Clinical Trials in Oncology
 2015-11-23 PHASE3
NCT05965219 COMPLETED
Healthy Volunteers
Cerevel Therapeutics, LLC
 2023-08-15 PHASE1
NCT05413369 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2022-07-07 PHASE3
NCT05413369 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2022-07-07 PHASE3
NCT03617458 COMPLETED
Pulmonary Artery Hypertension
Vanderbilt University Medical Center
 2018-08-23 PHASE2
NCT03617458 COMPLETED
Pulmonary Artery Hypertension
Vanderbilt University Medical Center
 2018-08-23 PHASE2
NCT06628544 COMPLETED
BCG Vaccination
Zhongnan Hospital
 2020-09-01 EARLY_PHASE1
NCT06628544 COMPLETED
BCG Vaccination
Zhongnan Hospital
 2020-09-01 EARLY_PHASE1
NCT06103747 COMPLETED
Fed Conditions
Reseach Laboratory of Clinical and Experimental Pharmacology
 2023-02-21 PHASE1
NCT06103747 COMPLETED
Fed Conditions
Reseach Laboratory of Clinical and Experimental Pharmacology
 2023-02-21 PHASE1
NCT05579977 TERMINATED
Diabetes Mellitus; Obesity
Pfizer
 2022-10-27 PHASE2
NCT05579977 TERMINATED
Diabetes Mellitus; Obesity
Pfizer
 2022-10-27 PHASE2
NCT05768360 COMPLETED
Healthy Male Subjects
AstraZeneca
 2023-04-25 PHASE1
NCT05768360 COMPLETED
Healthy Male Subjects
AstraZeneca
 2023-04-25 PHASE1
NCT03651895 COMPLETED
Chronic Obstructive Pulmonary Disease
Imperial College London
 2022-05-17 PHASE2
NCT03651895 COMPLETED
Chronic Obstructive Pulmonary Disease
Imperial College London
 2022-05-17 PHASE2
NCT05981742 COMPLETED
Polycystic Ovary Syndrome
Al-Rasheed University College
 2022-09-21 PHASE2
NCT05981742 COMPLETED
Polycystic Ovary Syndrome
Al-Rasheed University College
 2022-09-21 PHASE2
NCT06244550 COMPLETED
Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury
Taipei City Hospital
 2021-09-22
NCT06244550 COMPLETED
Non-alcoholic Fatty Liver Disease; Liver Fibrosis; Liver Injury
Taipei City Hospital
 2021-09-22
NCT05790577 COMPLETED
Melasma
Ishtiaq Ahmed
 2022-02-01 PHASE2
NCT05790577 COMPLETED
Melasma
Ishtiaq Ahmed
 2022-02-01 PHASE2
NCT06124547 COMPLETED
Bioequivalence; Diabetes Mellitus, Type 2
Galenicum Health
 2023-01-16 PHASE1
NCT06124547 COMPLETED
Bioequivalence; Diabetes Mellitus, Type 2
Galenicum Health
 2023-01-16 PHASE1
NCT03378297 COMPLETED
Ovarian Cancer
Haukeland University Hospital
 2018-05-04 EARLY_PHASE1
NCT03378297 COMPLETED
Ovarian Cancer
Haukeland University Hospital
 2018-05-04 EARLY_PHASE1
NCT05519813 UNKNOWN
Polycystic Ovary Syndrome
Bing He
 2022-01-01 PHASE4
NCT05519813 UNKNOWN
Polycystic Ovary Syndrome
Bing He
 2022-01-01 PHASE4
NCT06603480 COMPLETED
Methylglyoxal; PreDiabetes; Exercise; Metformin
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
 2021-04-08
NCT06603480 COMPLETED
Methylglyoxal; PreDiabetes; Exercise; Metformin
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
 2021-04-08
NCT04662866 UNKNOWN
Impaired Glucose Tolerance; Insulin Sensitivity; Glucose Metabolism Disorders
Oslo University Hospital
 2021-02-10 PHASE2
NCT02515773 COMPLETED
Bipolar Disorder
Melissa Delbello
 2015-12 PHASE4
NCT04662866 UNKNOWN
Impaired Glucose Tolerance; Insulin Sensitivity; Glucose Metabolism Disorders
Oslo University Hospital
 2021-02-10 PHASE2
NCT02515773 COMPLETED
Bipolar Disorder
Melissa Delbello
 2015-12 PHASE4
NCT03916263 COMPLETED
PCOS; Diet Modification; Metabolism; Nutrition Disorders
Texas Tech University Health Sciences Center
 2018-08-29 EARLY_PHASE1
NCT03916263 COMPLETED
PCOS; Diet Modification; Metabolism; Nutrition Disorders
Texas Tech University Health Sciences Center
 2018-08-29 EARLY_PHASE1
NCT05292573 UNKNOWN
Female
Chang Gung Memorial Hospital
 2018-08-01 PHASE3
NCT05292573 UNKNOWN
Female
Chang Gung Memorial Hospital
 2018-08-01 PHASE3
NCT04885712 COMPLETED
Type2 Diabetes
Boryung Pharmaceutical Co., Ltd
 2021-05-28 PHASE3
NCT04885712 COMPLETED
Type2 Diabetes
Boryung Pharmaceutical Co., Ltd
 2021-05-28 PHASE3
NCT03603080 TERMINATED
Obesity
Hartford Hospital
 2019-03-01 PHASE4
NCT03603080 TERMINATED
Obesity
Hartford Hospital
 2019-03-01 PHASE4
NCT04667143 UNKNOWN
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd.
 2021-01 PHASE3
NCT04741204 WITHDRAWN
Breast Cancer Stage; Insulin Resistance; Racial Bias
Woman's
 2022-09 PHASE4
NCT04667143 UNKNOWN
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd.
 2021-01 PHASE3
NCT04741204 WITHDRAWN
Breast Cancer Stage; Insulin Resistance; Racial Bias
Woman's
 2022-09 PHASE4
NCT02621489 COMPLETED
Atherosclerosis; Diabetes; Restenosis
Karolinska Institutet
 2015-12 PHASE4
NCT02621489 COMPLETED
Atherosclerosis; Diabetes; Restenosis
Karolinska Institutet
 2015-12 PHASE4
NCT04588259 COMPLETED
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2020-10-09 PHASE3
NCT04588259 COMPLETED
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2020-10-09 PHASE3
NCT04817215 UNKNOWN
Diabetes Mellitus, Type 2
King Hamad University Hospital, Bahrain
 2021-10 PHASE3
NCT04817215 UNKNOWN
Diabetes Mellitus, Type 2
King Hamad University Hospital, Bahrain
 2021-10 PHASE3
NCT03874000 UNKNOWN
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
 2019-03-08 PHASE2
NCT03874000 UNKNOWN
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
 2019-03-08 PHASE2
NCT02895750 COMPLETED
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens
 2017-08-30 PHASE2
NCT02895750 COMPLETED
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens
 2017-08-30 PHASE2
NCT04053621 UNKNOWN
Diabetes Mellitus, Type 2
Laboratorios Manuell SA
 2021-01
NCT04053621 UNKNOWN
Diabetes Mellitus, Type 2
Laboratorios Manuell SA
 2021-01
NCT04089280 COMPLETED
Diabetes Mellitus, Type 2; Metformin Adverse Reaction
Medical University of Silesia
 2018-10-16
NCT04089280 COMPLETED
Diabetes Mellitus, Type 2; Metformin Adverse Reaction
Medical University of Silesia
 2018-10-16
NCT04893148 UNKNOWN
Type 2 Diabetes Mellitus; Glucose, High Blood
Chungbuk National University Hospital
 2020-05-26 PHASE4
NCT04893148 UNKNOWN
Type 2 Diabetes Mellitus; Glucose, High Blood
Chungbuk National University Hospital
 2020-05-26 PHASE4
NCT05108350 UNKNOWN
Type II Diabetes
Shandong Suncadia Medicine Co., Ltd.
 2021-11-09 PHASE1
NCT05108350 UNKNOWN
Type II Diabetes
Shandong Suncadia Medicine Co., Ltd.
 2021-11-09 PHASE1
NCT04373967 UNKNOWN
Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 2020-04-29 PHASE3
NCT04373967 UNKNOWN
Type 2 Diabetes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 2020-04-29 PHASE3
NCT03018665 UNKNOWN
Diabetes Mellitus, Type 2
The First Hospital of Jilin University
 2017-02 PHASE4
NCT03018665 UNKNOWN
Diabetes Mellitus, Type 2
The First Hospital of Jilin University
 2017-02 PHASE4
NCT03477162 TERMINATED
Thoracic Neoplasm
Dartmouth-Hitchcock Medical Center
 2018-05-15 EARLY_PHASE1
NCT03477162 TERMINATED
Thoracic Neoplasm
Dartmouth-Hitchcock Medical Center
 2018-05-15 EARLY_PHASE1
NCT03618654 COMPLETED
Head and Neck Squamous Cell Carcinoma; Oral Cavity Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2018-11-01 EARLY_PHASE1
NCT03618654 COMPLETED
Head and Neck Squamous Cell Carcinoma; Oral Cavity Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2018-11-01 EARLY_PHASE1
NCT04617275 COMPLETED
Diabetes; Obesity
Pfizer
 2021-01-06 PHASE2
NCT04617275 COMPLETED
Diabetes; Obesity
Pfizer
 2021-01-06 PHASE2
NCT03764605 UNKNOWN
ADPKD
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
 2019-01-30 PHASE3
NCT03764605 UNKNOWN
ADPKD
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
 2019-01-30 PHASE3
NCT03510390 COMPLETED
Head and Neck Cancer; Oral Cavity Squamous Cell Carcinoma
Insel Gruppe AG, University Hospital Bern
 2018-06-13
NCT03510390 COMPLETED
Head and Neck Cancer; Oral Cavity Squamous Cell Carcinoma
Insel Gruppe AG, University Hospital Bern
 2018-06-13
NCT05083949 COMPLETED
Healthy
Boehringer Ingelheim
 2021-07-23 PHASE1
NCT05083949 COMPLETED
Healthy
Boehringer Ingelheim
 2021-07-23 PHASE1
NCT03441750 COMPLETED
PreDiabetes
Chinese Association of Geriatric Research
 2017-04-25 PHASE4
NCT03441750 COMPLETED
PreDiabetes
Chinese Association of Geriatric Research
 2017-04-25 PHASE4
NCT02949700 COMPLETED
Head and Neck Squamous Cell Carcinoma
Baylor College of Medicine
 2017-01-26 PHASE1; PHASE2
NCT02949700 COMPLETED
Head and Neck Squamous Cell Carcinoma
Baylor College of Medicine
 2017-01-26 PHASE1; PHASE2
NCT04607252 TERMINATED
Atypical Endometrial Hyperplasia
Fudan University
 2021-01-11 PHASE2; PHASE3
NCT04607252 TERMINATED
Atypical Endometrial Hyperplasia
Fudan University
 2021-01-11 PHASE2; PHASE3
NCT04829903 COMPLETED
Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Corporacion Parc Tauli
 2020-01-02
NCT04829903 COMPLETED
Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Corporacion Parc Tauli
 2020-01-02
NCT04590937 COMPLETED
Healthy
Boehringer Ingelheim
 2020-10-20 PHASE1
NCT04590937 COMPLETED
Healthy
Boehringer Ingelheim
 2020-10-20 PHASE1
NCT04131582 UNKNOWN
Prediabetic State; Insulin Resistance
Universidad de Guanajuato
 2019-09-01 PHASE3
NCT04131582 UNKNOWN
Prediabetic State; Insulin Resistance
Universidad de Guanajuato
 2019-09-01 PHASE3
NCT02874430 TERMINATED
Breast Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Uterine Corpus Cancer; Uterine Corpus Carcinosarcoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2016-06-08 PHASE2
NCT02874430 TERMINATED
Breast Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Uterine Corpus Cancer; Uterine Corpus Carcinosarcoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2016-06-08 PHASE2
NCT03184493 UNKNOWN
Liver Cancer
Guangxi Medical University
 2017-06-02 PHASE3
NCT03184493 UNKNOWN
Liver Cancer
Guangxi Medical University
 2017-06-02 PHASE3
NCT04116203 COMPLETED
Polycystic Ovary Syndrome; Lipid Metabolism Disorders
University of Alberta
 2016-06-30 PHASE1
NCT04116203 COMPLETED
Polycystic Ovary Syndrome; Lipid Metabolism Disorders
University of Alberta
 2016-06-30 PHASE1
NCT03445702 COMPLETED
Diabetes Mellitus, Type 2; Metformin Adverse Reaction
St. Louis University
 2018-10-15 EARLY_PHASE1
NCT03445702 COMPLETED
Diabetes Mellitus, Type 2; Metformin Adverse Reaction
St. Louis University
 2018-10-15 EARLY_PHASE1
NCT03398824 COMPLETED
Fanconi Anemia
Boston Children's Hospital
 2018-03-29 PHASE2
NCT03398824 COMPLETED
Fanconi Anemia
Boston Children's Hospital
 2018-03-29 PHASE2
NCT04485845 UNKNOWN
Metabolic Syndrome; Diabete Type 2; Kidney Insufficiency
Cairo University
 2019-11-01 PHASE4
NCT04485845 UNKNOWN
Metabolic Syndrome; Diabete Type 2; Kidney Insufficiency
Cairo University
 2019-11-01 PHASE4
NCT02506790 UNKNOWN
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
 2015-07 PHASE2
NCT02506777 UNKNOWN
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
 2015-07 PHASE2
NCT02506790 UNKNOWN
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
 2015-07 PHASE2
NCT02506777 UNKNOWN
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology
 2015-07 PHASE2
NCT03109873 COMPLETED
Larynx; Lip; Oral Cavity; Pharynx
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2017-01-05 EARLY_PHASE1
NCT03109873 COMPLETED
Larynx; Lip; Oral Cavity; Pharynx
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
 2017-01-05 EARLY_PHASE1
NCT02981329 COMPLETED
Sickle Cell Anemia; Sickle Cell Disease; Hemoglobin Disorder
Baylor College of Medicine
 2017-03-02 EARLY_PHASE1
NCT02981329 COMPLETED
Sickle Cell Anemia; Sickle Cell Disease; Hemoglobin Disorder
Baylor College of Medicine
 2017-03-02 EARLY_PHASE1
NCT04134650 UNKNOWN
Prediabetic State; Insulin Resistance
Universidad de Guanajuato
 2019-09-01 PHASE3
NCT04134650 UNKNOWN
Prediabetic State; Insulin Resistance
Universidad de Guanajuato
 2019-09-01 PHASE3
NCT04916093 COMPLETED
Diabetes Mellitus, Type 2
Beni-Suef University
 2019-12-20 PHASE4
NCT04916093 COMPLETED
Diabetes Mellitus, Type 2
Beni-Suef University
 2019-12-20 PHASE4
NCT03761134 TERMINATED
Type 2 Diabetes Mellitus
Sanofi
 2018-11-30 PHASE3
NCT03761134 TERMINATED
Type 2 Diabetes Mellitus
Sanofi
 2018-11-30 PHASE3
NCT02064881 UNKNOWN
Type 2 Diabetes
Laboratorios Silanes S.A. de C.V.
 2015-10 PHASE2; PHASE3
NCT02064881 UNKNOWN
Type 2 Diabetes
Laboratorios Silanes S.A. de C.V.
 2015-10 PHASE2; PHASE3
NCT03538704 UNKNOWN
Endometrial Cancer; Fertility
Peking University People's Hospital
 2015-01-01
NCT03538704 UNKNOWN
Endometrial Cancer; Fertility
Peking University People's Hospital
 2015-01-01
NCT03593538 COMPLETED
Smoking; HIV-1-infection
University of Pennsylvania
 2016-04-01 PHASE2
NCT03593538 COMPLETED
Smoking; HIV-1-infection
University of Pennsylvania
 2016-04-01 PHASE2
NCT02495103 TERMINATED
Renal Cell Carcinoma; Hereditary Leiomyomatosis; Renal Cell Cancer
National Cancer Institute (NCI)
 2015-08-26 PHASE1; PHASE2
NCT02495103 TERMINATED
Renal Cell Carcinoma; Hereditary Leiomyomatosis; Renal Cell Cancer
National Cancer Institute (NCI)
 2015-08-26 PHASE1; PHASE2
NCT03863405 UNKNOWN
Rheumatoid Arthritis
Ain Shams University
 2019-01-09 PHASE2
NCT03863405 UNKNOWN
Rheumatoid Arthritis
Ain Shams University
 2019-01-09 PHASE2
NCT04161404 UNKNOWN
Pharmacokinetics; Molecular Mechanisms of Pharmacological Action
University of Malaya
 2019-08-21 PHASE1
NCT04161404 UNKNOWN
Pharmacokinetics; Molecular Mechanisms of Pharmacological Action
University of Malaya
 2019-08-21 PHASE1
NCT02302326 COMPLETED
Polycystic Ovary Syndrome
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
 2013-01
NCT02302326 COMPLETED
Polycystic Ovary Syndrome
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
 2013-01
NCT04050098 UNKNOWN
Type2 Diabetes
LG Chem
 2019-11-01 PHASE1
NCT04050098 UNKNOWN
Type2 Diabetes
LG Chem
 2019-11-01 PHASE1
NCT04065581 COMPLETED
Diabetes Mellitus, Type 2
Bayer
 2019-10-14 PHASE1
NCT04065581 COMPLETED
Diabetes Mellitus, Type 2
Bayer
 2019-10-14 PHASE1
NCT02496741 COMPLETED
Glioma; Cholangiocarcinoma; Chondrosarcoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
 2015-11 PHASE1; PHASE2
NCT02496741 COMPLETED
Glioma; Cholangiocarcinoma; Chondrosarcoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
 2015-11 PHASE1; PHASE2
NCT03982238 COMPLETED
Type 2 Diabetes
Majianhua
 2019-06-15 PHASE4
NCT03982238 COMPLETED
Type 2 Diabetes
Majianhua
 2019-06-15 PHASE4
NCT01528046 COMPLETED
Solid Tumors; Primary Brain Tumors
H. Lee Moffitt Cancer Center and Research Institute
 2012-09-24 PHASE1
NCT01528046 COMPLETED
Solid Tumors; Primary Brain Tumors
H. Lee Moffitt Cancer Center and Research Institute
 2012-09-24 PHASE1
NCT03380091 TERMINATED
PCOS; Depression; Vitamin D Deficiency; Insulin Resistance
University of California, San Francisco
 2017-12-12 PHASE4
NCT03380091 TERMINATED
PCOS; Depression; Vitamin D Deficiency; Insulin Resistance
University of California, San Francisco
 2017-12-12 PHASE4
NCT04120259 COMPLETED
Diabetes Mellitus, Type 2
Ziauddin University
 2019-04-22
NCT04120259 COMPLETED
Diabetes Mellitus, Type 2
Ziauddin University
 2019-04-22
NCT04008186 COMPLETED
Healthy Adult Subjects
Biogen
 2019-06-14 PHASE1
NCT04008186 COMPLETED
Healthy Adult Subjects
Biogen
 2019-06-14 PHASE1
NCT03332771 COMPLETED
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals
 2017-12-01 PHASE3
NCT03332771 COMPLETED
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals
 2017-12-01 PHASE3
NCT06015594 COMPLETED
Polycystic Ovary Syndrome
University of Cagliari
 2015-01-01
NCT06015594 COMPLETED
Polycystic Ovary Syndrome
University of Cagliari
 2015-01-01
NCT03651531 TERMINATED
Gestational Diabetes
Women and Infants Hospital of Rhode Island
 2018-01-03 PHASE3
NCT03651531 TERMINATED
Gestational Diabetes
Women and Infants Hospital of Rhode Island
 2018-01-03 PHASE3
NCT03604419 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd.
 2018-06-13 PHASE2
NCT03604419 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd.
 2018-06-13 PHASE2
NCT04009603 COMPLETED
Polycystic Ovary Syndrome
Ziauddin University
 2018-12-06
NCT04009603 COMPLETED
Polycystic Ovary Syndrome
Ziauddin University
 2018-12-06
NCT03970434 COMPLETED
Healthy
Chonbuk National University Hospital
 2019-05-30 PHASE1
NCT03970434 COMPLETED
Healthy
Chonbuk National University Hospital
 2019-05-30 PHASE1
NCT03796975 COMPLETED
Type 2 Diabetes Mellitus; Non-alcoholic Fatty Liver Disease; Efficacy
Xijing Hospital
 2018-06-28 PHASE4
NCT03796975 COMPLETED
Type 2 Diabetes Mellitus; Non-alcoholic Fatty Liver Disease; Efficacy
Xijing Hospital
 2018-06-28 PHASE4
NCT03066830 COMPLETED
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals
 2017-02-24 PHASE3
NCT02065687 UNKNOWN
Endometrial Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Undifferentiated Carcinoma; Recurrent Uterine Corpus Carcinoma; Stage III Uterine Corpus Cancer AJCC v7; Stage IIIA Uterine Corpus Cancer AJCC v7; Stage IIIB Uterine Corpus Cancer AJCC v7; Stage IIIC Uterine Corpus Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7
Gynecologic Oncology Group
 2014-03-17 PHASE2; PHASE3
NCT03066830 COMPLETED
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals
 2017-02-24 PHASE3
NCT02065687 UNKNOWN
Endometrial Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Undifferentiated Carcinoma; Recurrent Uterine Corpus Carcinoma; Stage III Uterine Corpus Cancer AJCC v7; Stage IIIA Uterine Corpus Cancer AJCC v7; Stage IIIB Uterine Corpus Cancer AJCC v7; Stage IIIC Uterine Corpus Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7
Gynecologic Oncology Group
 2014-03-17 PHASE2; PHASE3
NCT02186847 COMPLETED
Adenosquamous Lung Carcinoma; Bronchioloalveolar Carcinoma; Large Cell Lung Carcinoma; Lung Adenocarcinoma; Non-Small Cell Lung Carcinoma; Recurrent Non-Small Cell Lung Carcinoma; Squamous Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer
NRG Oncology
 2014-08 PHASE2
NCT02186847 COMPLETED
Adenosquamous Lung Carcinoma; Bronchioloalveolar Carcinoma; Large Cell Lung Carcinoma; Lung Adenocarcinoma; Non-Small Cell Lung Carcinoma; Recurrent Non-Small Cell Lung Carcinoma; Squamous Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer
NRG Oncology
 2014-08 PHASE2
NCT03061214 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-08-28 PHASE3
NCT03061214 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2017-08-28 PHASE3
NCT01627067 TERMINATED
Breast Cancer
M.D. Anderson Cancer Center
 2012-09 PHASE2
NCT01627067 TERMINATED
Breast Cancer
M.D. Anderson Cancer Center
 2012-09 PHASE2
NCT01999686 COMPLETED
Polycystic Ovary Syndrome (PCOS); Insulin Resistance
Dexa Medica Group
 2014-10 PHASE3
NCT01999686 COMPLETED
Polycystic Ovary Syndrome (PCOS); Insulin Resistance
Dexa Medica Group
 2014-10 PHASE3
NCT03192293 UNKNOWN
Breast Cancer
National University Hospital, Singapore
 2017-01-20 PHASE2
NCT03192293 UNKNOWN
Breast Cancer
National University Hospital, Singapore
 2017-01-20 PHASE2
NCT05125575 COMPLETED
Pharmacokinetics
Joint Stock Company "Farmak"
 2019-01-11 PHASE1
NCT05125575 COMPLETED
Pharmacokinetics
Joint Stock Company "Farmak"
 2019-01-11 PHASE1
NCT03639545 UNKNOWN
Vascular Stiffness; Hypoglycemic Agents; Diabetes Complications; Diabetes Mellitus, Type 1
University Medical Centre Ljubljana
 2018-03-01 PHASE4
NCT03639545 UNKNOWN
Vascular Stiffness; Hypoglycemic Agents; Diabetes Complications; Diabetes Mellitus, Type 1
University Medical Centre Ljubljana
 2018-03-01 PHASE4
NCT00700856 UNKNOWN
Type 2 Diabetes Mellitus; Cardiovascular Disease
Italian Society of Diabetology
 2008-09 PHASE4
NCT02984475 UNKNOWN
Beta Thalassemia Major Anemia
Cairo University
 2016-12 PHASE4
NCT02846233 COMPLETED
Type 2 Diabetes Mellitus
University of California, San Francisco
 2016-08
NCT00700856 UNKNOWN
Type 2 Diabetes Mellitus; Cardiovascular Disease
Italian Society of Diabetology
 2008-09 PHASE4
NCT02984475 UNKNOWN
Beta Thalassemia Major Anemia
Cairo University
 2016-12 PHASE4
NCT02846233 COMPLETED
Type 2 Diabetes Mellitus
University of California, San Francisco
 2016-08
NCT02689843 COMPLETED
Polycystic Ovary Syndrome
Shiraz University of Medical Sciences
 2018-02-01 EARLY_PHASE1
NCT03772262 COMPLETED
Interaction Drug Food
Washington State University
 2018-04-05 EARLY_PHASE1
NCT02689843 COMPLETED
Polycystic Ovary Syndrome
Shiraz University of Medical Sciences
 2018-02-01 EARLY_PHASE1
NCT03772262 COMPLETED
Interaction Drug Food
Washington State University
 2018-04-05 EARLY_PHASE1
NCT01140438 COMPLETED
Diabetes
Norwegian University of Science and Technology
 2009-03
NCT01140438 COMPLETED
Diabetes
Norwegian University of Science and Technology
 2009-03
NCT02752412 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-05-17 PHASE3
NCT02752412 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-05-17 PHASE3
NCT02694289 WITHDRAWN
Type 2 Diabetes Mellitus
Maya Guglin
 2016-11
NCT02694289 WITHDRAWN
Type 2 Diabetes Mellitus
Maya Guglin
 2016-11
NCT04088461 COMPLETED
Prediabetic State; Impaired Glucose Tolerance; Insulin Resistance
Universidad de Guanajuato
 2016-09 PHASE4
NCT04088461 COMPLETED
Prediabetic State; Impaired Glucose Tolerance; Insulin Resistance
Universidad de Guanajuato
 2016-09 PHASE4
NCT01804049 COMPLETED
Prediabetes
VA Office of Research and Development
 2014-04-08 PHASE1; PHASE2
NCT01804049 COMPLETED
Prediabetes
VA Office of Research and Development
 2014-04-08 PHASE1; PHASE2
NCT03214380 COMPLETED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2017-07-14 PHASE3
NCT03214380 COMPLETED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2017-07-14 PHASE3
NCT04426422 COMPLETED
Type 2 Diabetes
Shenzhen People's Hospital
 2017-03-01 PHASE4
NCT04426422 COMPLETED
Type 2 Diabetes
Shenzhen People's Hospital
 2017-03-01 PHASE4
NCT02787551 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-07-06 PHASE3
NCT02787551 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2016-07-06 PHASE3
NCT01980823 COMPLETED
Breast Cancer; Breast Tumors; Cancer of Breast
Columbia University
 2013-10 EARLY_PHASE1
NCT01980823 COMPLETED
Breast Cancer; Breast Tumors; Cancer of Breast
Columbia University
 2013-10 EARLY_PHASE1
NCT03216278 COMPLETED
Healthy Subjects in Fasted and Fed State
AstraZeneca
 2017-09-26 PHASE1
NCT03216278 COMPLETED
Healthy Subjects in Fasted and Fed State
AstraZeneca
 2017-09-26 PHASE1
NCT03467971 COMPLETED
Healthy
Merck KGaA, Darmstadt, Germany
 2018-03-06 PHASE1
NCT03467971 COMPLETED
Healthy
Merck KGaA, Darmstadt, Germany
 2018-03-06 PHASE1
NCT02831361 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2016-10-17 PHASE3
NCT02831361 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2016-10-17 PHASE3
NCT02308228 COMPLETED
Aging
Philip Kern
 2015-01-14 EARLY_PHASE1
NCT02308228 COMPLETED
Aging
Philip Kern
 2015-01-14 EARLY_PHASE1
NCT02467920 COMPLETED
Type 2 Diabetes Mellitus
Huazhong University of Science and Technology
 2015-08 PHASE4
NCT02467920 COMPLETED
Type 2 Diabetes Mellitus
Huazhong University of Science and Technology
 2015-08 PHASE4
NCT02827903 COMPLETED
Type 2 Diabetes; Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2016-01-15 PHASE3
NCT02827903 COMPLETED
Type 2 Diabetes; Dyslipidemia
Jeil Pharmaceutical Co., Ltd.
 2016-01-15 PHASE3
NCT03259490 COMPLETED
Healthy
Boehringer Ingelheim
 2017-08-31 PHASE1
NCT03259490 COMPLETED
Healthy
Boehringer Ingelheim
 2017-08-31 PHASE1
NCT01755468 COMPLETED
Type 2 Diabetes
Mount Sinai Hospital, Canada
 2013-04 PHASE3
NCT02437812 UNKNOWN
Epithelial Ovarian Carcinoma
Gynecologic Oncology Associates
 2014-01 PHASE2
NCT01755468 COMPLETED
Type 2 Diabetes
Mount Sinai Hospital, Canada
 2013-04 PHASE3
NCT02437812 UNKNOWN
Epithelial Ovarian Carcinoma
Gynecologic Oncology Associates
 2014-01 PHASE2
NCT02548741 UNKNOWN
Type 2 Diabetes Mellitus
University of Arizona
 2015-09
NCT02548741 UNKNOWN
Type 2 Diabetes Mellitus
University of Arizona
 2015-09
NCT01779375 COMPLETED
Prediabetes; Type 2 Diabetes
RISE Study Group
 2013-06-16 PHASE3
NCT01779375 COMPLETED
Prediabetes; Type 2 Diabetes
RISE Study Group
 2013-06-16 PHASE3
NCT02511665 UNKNOWN
Prostate Cancer
Guy's and St Thomas' NHS Foundation Trust
 2015-07 PHASE4
NCT02511665 UNKNOWN
Prostate Cancer
Guy's and St Thomas' NHS Foundation Trust
 2015-07 PHASE4
NCT03320694 COMPLETED
Gestational Diabetes Mellitus in Pregnancy
Services Institute of Medical Sciences, Pakistan
 2016-02-01 PHASE3
NCT03320694 COMPLETED
Gestational Diabetes Mellitus in Pregnancy
Services Institute of Medical Sciences, Pakistan
 2016-02-01 PHASE3
NCT02460354 TERMINATED
Diabetes Insipidus
Emory University
 2015-09 PHASE1
NCT02475070 COMPLETED
Type 2 Diabetes
Lund University
 2016-01 PHASE4
NCT02256189 COMPLETED
Type 2 Diabetes
Lund University
 2015-04 PHASE4
NCT02460354 TERMINATED
Diabetes Insipidus
Emory University
 2015-09 PHASE1
NCT01579812 COMPLETED
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
University of Michigan Rogel Cancer Center
 2011-10 PHASE2
NCT03000218 UNKNOWN
Overweight; Abnormal Liver Function Tests
Seoul National University Hospital
 2016-08 PHASE1
NCT02475070 COMPLETED
Type 2 Diabetes
Lund University
 2016-01 PHASE4
NCT01579812 COMPLETED
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
University of Michigan Rogel Cancer Center
 2011-10 PHASE2
NCT03000218 UNKNOWN
Overweight; Abnormal Liver Function Tests
Seoul National University Hospital
 2016-08 PHASE1
NCT02256189 COMPLETED
Type 2 Diabetes
Lund University
 2015-04 PHASE4
NCT02551874 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2015-10-20 PHASE3
NCT02551874 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2015-10-20 PHASE3
NCT02887625 UNKNOWN
Type 2 Diabetes
Dr. Muhammad Abdulghani
 2015-02
NCT02887625 UNKNOWN
Type 2 Diabetes
Dr. Muhammad Abdulghani
 2015-02
NCT02278965 COMPLETED
Stage 0 Breast Carcinoma; Breast Neoplasms; Stage I Breast Carcinoma; Stage II Breast Carcinoma; Stage III Breast Carcinoma
Katherine D. Crew
 2015-01-22 PHASE1
NCT02278965 COMPLETED
Stage 0 Breast Carcinoma; Breast Neoplasms; Stage I Breast Carcinoma; Stage II Breast Carcinoma; Stage III Breast Carcinoma
Katherine D. Crew
 2015-01-22 PHASE1
NCT03167918 COMPLETED
Type 2 Diabetes Mellitus; Pulmonary Function
Liaoning University of Traditional Chinese Medicine
 2014-07-21 PHASE2; PHASE3
NCT03167918 COMPLETED
Type 2 Diabetes Mellitus; Pulmonary Function
Liaoning University of Traditional Chinese Medicine
 2014-07-21 PHASE2; PHASE3
NCT02951260 COMPLETED
Diabetes Mellitus, Type 2
Rigshospitalet, Denmark
 2016-10
NCT02951260 COMPLETED
Diabetes Mellitus, Type 2
Rigshospitalet, Denmark
 2016-10
NCT02069379 COMPLETED
Depression; Insulin Resistance; Metabolic Syndrome
University of Michigan
 2014-07 PHASE4
NCT01813929 COMPLETED
Type 1 Diabetes
University of Colorado, Denver
 2011-06 PHASE4
NCT02069379 COMPLETED
Depression; Insulin Resistance; Metabolic Syndrome
University of Michigan
 2014-07 PHASE4
NCT01813929 COMPLETED
Type 1 Diabetes
University of Colorado, Denver
 2011-06 PHASE4
NCT03458208 COMPLETED
Bioequivalence
Geropharm
 2017-02-14 PHASE1
NCT03458208 COMPLETED
Bioequivalence
Geropharm
 2017-02-14 PHASE1
NCT02437656 COMPLETED
Rectal Cancer
Centre Oscar Lambret
 2015-05 PHASE2
NCT02956044 COMPLETED
Type2 Diabetes Mellitus
Theracos
 2016-11 PHASE1
NCT02437656 COMPLETED
Rectal Cancer
Centre Oscar Lambret
 2015-05 PHASE2
NCT02956044 COMPLETED
Type2 Diabetes Mellitus
Theracos
 2016-11 PHASE1
NCT02005419 COMPLETED
Stage IA Pancreatic Adenocarcinoma; Stage IB Pancreatic Adenocarcinoma; Stage IIA Pancreatic Adenocarcinoma; Stage IIB Pancreatic Adenocarcinoma
Xian-Jun Yu
 2013-12 PHASE2
NCT02005419 COMPLETED
Stage IA Pancreatic Adenocarcinoma; Stage IB Pancreatic Adenocarcinoma; Stage IIA Pancreatic Adenocarcinoma; Stage IIB Pancreatic Adenocarcinoma
Xian-Jun Yu
 2013-12 PHASE2
NCT03106870 COMPLETED
Gestational Diabetes Mellitus in Pregnancy
Ain Shams University
 2016-06
NCT03106870 COMPLETED
Gestational Diabetes Mellitus in Pregnancy
Ain Shams University
 2016-06
NCT02145559 COMPLETED
Breast Neoplasms; Lung Neoplasms; Cancer of Liver; Lymphoma; Cancer of Kidney
University of Chicago
 2014-04 PHASE1
NCT02145559 COMPLETED
Breast Neoplasms; Lung Neoplasms; Cancer of Liver; Lymphoma; Cancer of Kidney
University of Chicago
 2014-04 PHASE1
NCT02851095 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-08 PHASE1
NCT02851095 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-08 PHASE1
NCT03165877 COMPLETED
Diabetes Mellitus, Type 2
Universidad de Valparaiso
 2016-05-31
NCT03165877 COMPLETED
Diabetes Mellitus, Type 2
Universidad de Valparaiso
 2016-05-31
NCT02821910 COMPLETED
Healthy
Boehringer Ingelheim
 2016-07-20 PHASE1
NCT02821910 COMPLETED
Healthy
Boehringer Ingelheim
 2016-07-20 PHASE1
NCT01910246 WITHDRAWN
Insulin Resistance
University of California, San Francisco
 2015-04 PHASE4
NCT02438397 UNKNOWN
Type 2 Diabetes
Shanghai 6th People's Hospital
 2014-12 PHASE4
NCT02851212 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-08 PHASE1
NCT01910246 WITHDRAWN
Insulin Resistance
University of California, San Francisco
 2015-04 PHASE4
NCT02851212 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-08 PHASE1
NCT02438397 UNKNOWN
Type 2 Diabetes
Shanghai 6th People's Hospital
 2014-12 PHASE4
NCT02284893 COMPLETED
Type 2 Diabetes
AstraZeneca
 2014-09-09 PHASE3
NCT02284893 COMPLETED
Type 2 Diabetes
AstraZeneca
 2014-09-09 PHASE3
NCT02819869 TERMINATED
Hepatocellular Carcinoma
Taipei Medical University WanFang Hospital
 2016-08-01 PHASE2
NCT02819869 TERMINATED
Hepatocellular Carcinoma
Taipei Medical University WanFang Hospital
 2016-08-01 PHASE2
NCT02463357 COMPLETED
Mountain Sickness
University of Colorado, Denver
 2015-08 PHASE4
NCT02463357 COMPLETED
Mountain Sickness
University of Colorado, Denver
 2015-08 PHASE4
NCT02402348 TERMINATED
Cancer of Head and Neck
West Virginia University
 2014-12 EARLY_PHASE1
NCT02941445 COMPLETED
Polycystic Ovary Syndrome; Body Weight
University Medical Centre Ljubljana
 2015-10 PHASE4
NCT02554877 COMPLETED
Type 2 Diabetes Mellitus
Pfizer
 2015-10 PHASE2
NCT02273050 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2014-12 PHASE3
NCT02402348 TERMINATED
Cancer of Head and Neck
West Virginia University
 2014-12 EARLY_PHASE1
NCT02941445 COMPLETED
Polycystic Ovary Syndrome; Body Weight
University Medical Centre Ljubljana
 2015-10 PHASE4
NCT02554877 COMPLETED
Type 2 Diabetes Mellitus
Pfizer
 2015-10 PHASE2
NCT02273050 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2014-12 PHASE3
NCT02531308 TERMINATED
Diffuse Large B-Cell Lymphoma
Rush University Medical Center
 2015-07 PHASE2
NCT02179788 COMPLETED
Low Milk Supply; Pre-diabetes; Insulin Resistance; Suppressed Lactation
Children's Hospital Medical Center, Cincinnati
 2014-06 PHASE1; PHASE2
NCT02633488 COMPLETED
Metabolic Syndrome; Insulin Sensitivity
University of Virginia
 2014-06
NCT02815397 TERMINATED
Diffuse Large B-Cell Lymphoma
Rush University Medical Center
 2016-02 PHASE2
NCT02325960 COMPLETED
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2015-01 PHASE4
NCT01620593 COMPLETED
Prostate Cancer
The University of Texas Health Science Center at San Antonio
 2011-04 PHASE2
NCT02531308 TERMINATED
Diffuse Large B-Cell Lymphoma
Rush University Medical Center
 2015-07 PHASE2
NCT02179788 COMPLETED
Low Milk Supply; Pre-diabetes; Insulin Resistance; Suppressed Lactation
Children's Hospital Medical Center, Cincinnati
 2014-06 PHASE1; PHASE2
NCT02325960 COMPLETED
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
 2015-01 PHASE4
NCT02633488 COMPLETED
Metabolic Syndrome; Insulin Sensitivity
University of Virginia
 2014-06
NCT01620593 COMPLETED
Prostate Cancer
The University of Texas Health Science Center at San Antonio
 2011-04 PHASE2
NCT02815397 TERMINATED
Diffuse Large B-Cell Lymphoma
Rush University Medical Center
 2016-02 PHASE2
NCT02611518 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-04-05 PHASE1
NCT02611518 COMPLETED
Healthy
Janssen Research & Development, LLC
 2016-04-05 PHASE1
NCT02036515 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2014-03-12 PHASE3
NCT02036515 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2014-03-12 PHASE3
NCT02644954 UNKNOWN
Psoriasis
Post Graduate Institute of Medical Education and Research, Chandigarh
 2016-01 PHASE3
NCT02470546 UNKNOWN
Liver Cirrhosis; Hepatic Encephalopathy
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
 2015-03 PHASE4
NCT02470546 UNKNOWN
Liver Cirrhosis; Hepatic Encephalopathy
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
 2015-03 PHASE4
NCT02644954 UNKNOWN
Psoriasis
Post Graduate Institute of Medical Education and Research, Chandigarh
 2016-01 PHASE3
NCT01690091 COMPLETED
Insulin Resistance; Chronic Heart Failure
Institute for Clinical and Experimental Medicine
 2012-11 PHASE2; PHASE3
NCT03207698 COMPLETED
Furcation Defects
Government Dental College and Research Institute, Bangalore
 2015-09 PHASE2; PHASE3
NCT01690091 COMPLETED
Insulin Resistance; Chronic Heart Failure
Institute for Clinical and Experimental Medicine
 2012-11 PHASE2; PHASE3
NCT03207698 COMPLETED
Furcation Defects
Government Dental College and Research Institute, Bangalore
 2015-09 PHASE2; PHASE3
NCT02229396 COMPLETED
Diabetes Mellitus
AstraZeneca
 2014-09-04 PHASE3
NCT02229396 COMPLETED
Diabetes Mellitus
AstraZeneca
 2014-09-04 PHASE3
NCT02637037 COMPLETED
Bioequivalence; Fixed Dose Combination Tablets; Healthy Male and Female Subjects
AstraZeneca
 2015-12-21 PHASE1
NCT02637037 COMPLETED
Bioequivalence; Fixed Dose Combination Tablets; Healthy Male and Female Subjects
AstraZeneca
 2015-12-21 PHASE1
NCT02106104 COMPLETED
Type 2 Diabetes
Amsterdam UMC, location VUmc
 2014-03 PHASE4
NCT02106104 COMPLETED
Type 2 Diabetes
Amsterdam UMC, location VUmc
 2014-03 PHASE4
NCT01755156 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2013-01-11 PHASE3
NCT01755156 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2013-01-11 PHASE3
NCT02813863 COMPLETED
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.
 2015-12 PHASE1
NCT02813863 COMPLETED
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.
 2015-12 PHASE1
NCT01302002 WITHDRAWN
Breast Cancer
Instituto Nacional de Cancer, Brazil
 2011-01 EARLY_PHASE1
NCT01302002 WITHDRAWN
Breast Cancer
Instituto Nacional de Cancer, Brazil
 2011-01 EARLY_PHASE1
NCT02411825 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2015-03 PHASE1
NCT02411825 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2015-03 PHASE1
NCT01965756 COMPLETED
Alzheimer's Disease; Vascular Dementia; Dementia; Memory Impairment
University of Pennsylvania
 2013-01 PHASE2
NCT01965756 COMPLETED
Alzheimer's Disease; Vascular Dementia; Dementia; Memory Impairment
University of Pennsylvania
 2013-01 PHASE2
NCT02574845 COMPLETED
Healthy
Boehringer Ingelheim
 2015-10-12 PHASE1
NCT02574845 COMPLETED
Healthy
Boehringer Ingelheim
 2015-10-12 PHASE1
NCT05480007 COMPLETED
NAFLD
Shanghai 10th People's Hospital
 2011-01-30
NCT05480007 COMPLETED
NAFLD
Shanghai 10th People's Hospital
 2011-01-30
NCT02401880 COMPLETED
Type 2 Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH
 2015-05 PHASE4
NCT02443922 UNKNOWN
Type 2 Diabetes
Foundation for the National Institutes of Health
 2015-06
NCT02401880 COMPLETED
Type 2 Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH
 2015-05 PHASE4
NCT02443922 UNKNOWN
Type 2 Diabetes
Foundation for the National Institutes of Health
 2015-06
NCT02026310 COMPLETED
Diabetes Mellitus, Type 2
Qifu Li
 2014-01
NCT02026310 COMPLETED
Diabetes Mellitus, Type 2
Qifu Li
 2014-01
NCT02111096 TERMINATED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2014-04 PHASE2
NCT02435277 COMPLETED
Type 2 Diabetes Mellitus
NuSirt Biopharma
 2014-10 PHASE2
NCT02111096 TERMINATED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2014-04 PHASE2
NCT02435277 COMPLETED
Type 2 Diabetes Mellitus
NuSirt Biopharma
 2014-10 PHASE2
NCT01879293 COMPLETED
Left Ventriclar Mass
Wuhan General Hospital of Guangzhou Military Command
 2013-07 PHASE4
NCT02288273 COMPLETED
Type 2 Diabetes
AstraZeneca
 2014-12 PHASE4
NCT01879293 COMPLETED
Left Ventriclar Mass
Wuhan General Hospital of Guangzhou Military Command
 2013-07 PHASE4
NCT02288273 COMPLETED
Type 2 Diabetes
AstraZeneca
 2014-12 PHASE4
NCT01589653 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-05-26 PHASE4
NCT01589653 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-05-26 PHASE4
NCT01907854 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12-02 PHASE4
NCT01907854 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12-02 PHASE4
NCT01544751 UNKNOWN
Nonalcoholic Fatty Liver Disease (NAFLD)
Prof Antonino Belfiore
 2011-09
NCT02710448 COMPLETED
Renal Disorder Associated With Type II Diabetes Mellitus
Centre Hospitalier Universitaire, Amiens
 2012-06 PHASE2
NCT02778776 COMPLETED
Metabolic Syndrome
Centro Universitario de Ciencias de la Salud, Mexico
 2013-01 PHASE3
NCT02710448 COMPLETED
Renal Disorder Associated With Type II Diabetes Mellitus
Centre Hospitalier Universitaire, Amiens
 2012-06 PHASE2
NCT01544751 UNKNOWN
Nonalcoholic Fatty Liver Disease (NAFLD)
Prof Antonino Belfiore
 2011-09
NCT02778776 COMPLETED
Metabolic Syndrome
Centro Universitario de Ciencias de la Salud, Mexico
 2013-01 PHASE3
NCT02342925 COMPLETED
Healthy Volunteer
Hoffmann-La Roche
 2015-02 PHASE1
NCT02342925 COMPLETED
Healthy Volunteer
Hoffmann-La Roche
 2015-02 PHASE1
NCT02249910 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2014-09-18 PHASE1
NCT02249910 COMPLETED
Diabetes; Healthy
Novo Nordisk A/S
 2014-09-18 PHASE1
NCT01787396 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2013-04 PHASE3
NCT01787396 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2013-04 PHASE3
NCT02002221 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals
 2013-12 PHASE4
NCT03030300 COMPLETED
Type2 Diabetes
Qianfoshan Hospital
 2008-01 PHASE4
NCT02002221 COMPLETED
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals
 2013-12 PHASE4
NCT02020616 TERMINATED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2013-12 PHASE1; PHASE2
NCT03030300 COMPLETED
Type2 Diabetes
Qianfoshan Hospital
 2008-01 PHASE4
NCT02020616 TERMINATED
Type 2 Diabetes Mellitus
Eli Lilly and Company
 2013-12 PHASE1; PHASE2
NCT01632020 TERMINATED
Colorectal Neoplasms
University of Arkansas
 2012-08 PHASE2
NCT02751307 COMPLETED
Metabolic Syndrome
Taipei Medical University WanFang Hospital
 2013-05 PHASE4
NCT02042664 COMPLETED
Obesity; Diabetes
Assistance Publique Hopitaux De Marseille
 2011-01 PHASE3
NCT01632020 TERMINATED
Colorectal Neoplasms
University of Arkansas
 2012-08 PHASE2
NCT02042664 COMPLETED
Obesity; Diabetes
Assistance Publique Hopitaux De Marseille
 2011-01 PHASE3
NCT02751307 COMPLETED
Metabolic Syndrome
Taipei Medical University WanFang Hospital
 2013-05 PHASE4
NCT01960205 UNKNOWN
Prediabetes
Shandong Provincial Hospital
 2013-08 PHASE4
NCT01960205 UNKNOWN
Prediabetes
Shandong Provincial Hospital
 2013-08 PHASE4
NCT02266472 COMPLETED
Healthy
Boehringer Ingelheim
 2014-11 PHASE1
NCT02266472 COMPLETED
Healthy
Boehringer Ingelheim
 2014-11 PHASE1
NCT01841697 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2013-06-13 PHASE3
NCT01841697 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2013-06-13 PHASE3
NCT02949193 COMPLETED
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.
 2013-05 PHASE3
NCT02008682 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12 PHASE4
NCT02008682 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2013-12 PHASE4
NCT02949193 COMPLETED
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd.
 2013-05 PHASE3
NCT01733836 WITHDRAWN
Prostate Cancer
University Health Network, Toronto
 2013-01 PHASE2
NCT01733836 WITHDRAWN
Prostate Cancer
University Health Network, Toronto
 2013-01 PHASE2
NCT02125227 COMPLETED
Healthy
Yuhan Corporation
 2014-04 PHASE1
NCT01933256 COMPLETED
Type 2 Diabetes Mellitus
CureDM
 2013-08 PHASE1
NCT02125227 COMPLETED
Healthy
Yuhan Corporation
 2014-04 PHASE1
NCT01933256 COMPLETED
Type 2 Diabetes Mellitus
CureDM
 2013-08 PHASE1
NCT01646320 COMPLETED
Type 2 Diabetes
AstraZeneca
 2012-09 PHASE3
NCT01816659 TERMINATED
Colorectal Carcinoma
M.D. Anderson Cancer Center
 2013-05 PHASE1
NCT01646320 COMPLETED
Type 2 Diabetes
AstraZeneca
 2012-09 PHASE3
NCT01816659 TERMINATED
Colorectal Carcinoma
M.D. Anderson Cancer Center
 2013-05 PHASE1
NCT02109679 COMPLETED
Healthy
Boehringer Ingelheim
 2014-05 PHASE1
NCT01561482 WITHDRAWN
Prostate Carcinoma
Nicholas Mitsiades
 2012-01 PHASE2
NCT01524705 COMPLETED
Type 2 Diabetes
University of Washington
 2012-08 PHASE4
NCT02077803 COMPLETED
Healthy
Janssen Research & Development, LLC
 2014-03 PHASE1
NCT01561482 WITHDRAWN
Prostate Carcinoma
Nicholas Mitsiades
 2012-01 PHASE2
NCT01524705 COMPLETED
Type 2 Diabetes
University of Washington
 2012-08 PHASE4
NCT02109679 COMPLETED
Healthy
Boehringer Ingelheim
 2014-05 PHASE1
NCT02077803 COMPLETED
Healthy
Janssen Research & Development, LLC
 2014-03 PHASE1
NCT03787043 COMPLETED
Healthy Volunteers
Handok Inc.
 2014-05 PHASE1
NCT02106923 COMPLETED
Healthy
Boehringer Ingelheim
 2014-04 PHASE1
NCT01895569 UNKNOWN
Type 2 Diabetes Mellitus
University of Pavia
 2013-06 PHASE4
NCT03787043 COMPLETED
Healthy Volunteers
Handok Inc.
 2014-05 PHASE1
NCT02106923 COMPLETED
Healthy
Boehringer Ingelheim
 2014-04 PHASE1
NCT01895569 UNKNOWN
Type 2 Diabetes Mellitus
University of Pavia
 2013-06 PHASE4
NCT02188654 COMPLETED
Psoriatic Arthritis
University of Alexandria
 2013-09
NCT01650181 COMPLETED
Liver Disease
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
 2011-11 PHASE4
NCT02188654 COMPLETED
Psoriatic Arthritis
University of Alexandria
 2013-09
NCT01650181 COMPLETED
Liver Disease
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
 2011-11 PHASE4
NCT02039245 COMPLETED
Healthy Volunteers
Janssen Research & Development, LLC
 2014-01 PHASE1
NCT02048761 UNKNOWN
Intrabony Defects in Chronic Periodontitis
Government Dental College and Research Institute, Bangalore
 2013-08 PHASE2
NCT02039245 COMPLETED
Healthy Volunteers
Janssen Research & Development, LLC
 2014-01 PHASE1
NCT02048761 UNKNOWN
Intrabony Defects in Chronic Periodontitis
Government Dental College and Research Institute, Bangalore
 2013-08 PHASE2
NCT01935804 COMPLETED
Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Metabolism Disorders
King Abdulaziz University
 2009-01 PHASE2
NCT01935804 COMPLETED
Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Metabolism Disorders
King Abdulaziz University
 2009-01 PHASE2
NCT00883259 UNKNOWN
Obesity; Polycystic Ovary Syndrome; Gestational Diabetes
University Magna Graecia
 2013-09 PHASE4
NCT01717911 UNKNOWN
Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan
 2010-09 PHASE4
NCT00883259 UNKNOWN
Obesity; Polycystic Ovary Syndrome; Gestational Diabetes
University Magna Graecia
 2013-09 PHASE4
NCT01717911 UNKNOWN
Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan
 2010-09 PHASE4
NCT02011633 COMPLETED
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
 2013-10 PHASE1
NCT02011633 COMPLETED
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
 2013-10 PHASE1
NCT00993187 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2010-05-04 PHASE4
NCT00993187 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2010-05-04 PHASE4
NCT01617434 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-09 PHASE3
NCT01617434 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2012-09 PHASE3
NCT01871415 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2013-05 PHASE3
NCT01845077 COMPLETED
Healthy
Boehringer Ingelheim
 2013-05 PHASE1
NCT01871415 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2013-05 PHASE3
NCT01845077 COMPLETED
Healthy
Boehringer Ingelheim
 2013-05 PHASE1
NCT01658501 COMPLETED
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc.
 2012-07 PHASE2
NCT01658501 COMPLETED
Type 2 Diabetes Mellitus
PhaseBio Pharmaceuticals Inc.
 2012-07 PHASE2
NCT02026869 UNKNOWN
PCOS
Assiut University
 2013-01 EARLY_PHASE1
NCT02026869 UNKNOWN
PCOS
Assiut University
 2013-01 EARLY_PHASE1
NCT01486043 TERMINATED
Acute Lymphoblastic Leukemia; Hyperglycemia; Insulin Resistance; Diabetes Mellitus
Children's Hospital Los Angeles
 2011-12
NCT01529541 COMPLETED
Type 2 Diabetes Mellitus
JW Pharmaceutical
 2011-05 PHASE3
NCT01486043 TERMINATED
Acute Lymphoblastic Leukemia; Hyperglycemia; Insulin Resistance; Diabetes Mellitus
Children's Hospital Los Angeles
 2011-12
NCT01529541 COMPLETED
Type 2 Diabetes Mellitus
JW Pharmaceutical
 2011-05 PHASE3
NCT01755494 COMPLETED
Type 2 Diabetes Mellitus(T2DM)
AstraZeneca
 2013-02 PHASE1
NCT01780051 COMPLETED
Diabetes Mellitus, Type 2
Dalim BioTech Co., Ltd.
 2013-03 PHASE1
NCT01368081 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2011-05 PHASE3
NCT01755494 COMPLETED
Type 2 Diabetes Mellitus(T2DM)
AstraZeneca
 2013-02 PHASE1
NCT01780051 COMPLETED
Diabetes Mellitus, Type 2
Dalim BioTech Co., Ltd.
 2013-03 PHASE1
NCT01368081 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2011-05 PHASE3
NCT01765946 COMPLETED
Insulin Resistance; Prediabetes; Aging; Inflammation
University of Padova
 2010-06 PHASE4
NCT01775579 COMPLETED
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
 2013-01 PHASE1
NCT01775579 COMPLETED
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited
 2013-01 PHASE1
NCT01765946 COMPLETED
Insulin Resistance; Prediabetes; Aging; Inflammation
University of Padova
 2010-06 PHASE4
NCT04569214 WITHDRAWN
Type II Diabetes
Boston Therapeutics
 2012-09 PHASE2
NCT04569214 WITHDRAWN
Type II Diabetes
Boston Therapeutics
 2012-09 PHASE2
NCT00399204 WITHDRAWN
Type 2 Diabetes
Post Graduate Institute of Medical Education and Research, Chandigarh
 2006-01 PHASE4
NCT00736385 TERMINATED
Fatty Liver
Duke University
 2009-04 PHASE4
NCT01831674 COMPLETED
Fasting
IPCA Laboratories Ltd.
 2012-12 PHASE1
NCT01674348 TERMINATED
Type 2 Diabetes Mellitus
Piramal Enterprises Limited
 2011-04 PHASE2
NCT00657943 COMPLETED
Type 2 Diabetes; Atherosclerosis; Arteriosclerosis
Steno Diabetes Center Copenhagen
 2008-04 PHASE4
NCT00399204 WITHDRAWN
Type 2 Diabetes
Post Graduate Institute of Medical Education and Research, Chandigarh
 2006-01 PHASE4
NCT00736385 TERMINATED
Fatty Liver
Duke University
 2009-04 PHASE4
NCT01831674 COMPLETED
Fasting
IPCA Laboratories Ltd.
 2012-12 PHASE1
NCT01674348 TERMINATED
Type 2 Diabetes Mellitus
Piramal Enterprises Limited
 2011-04 PHASE2
NCT00657943 COMPLETED
Type 2 Diabetes; Atherosclerosis; Arteriosclerosis
Steno Diabetes Center Copenhagen
 2008-04 PHASE4
NCT01565096 UNKNOWN
Diabetes Mellitus Type II
ikfe-CRO GmbH
 2011-11 PHASE4
NCT01565096 UNKNOWN
Diabetes Mellitus Type II
ikfe-CRO GmbH
 2011-11 PHASE4
NCT01117350 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2010-07 PHASE4
NCT01117350 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2010-07 PHASE4
NCT00960661 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2009-09 PHASE3
NCT00960661 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2009-09 PHASE3
NCT00510705 TERMINATED
Severe Coronary Artery Disease; Obesity; Impaired Glucose Tolerance
University of Leipzig
 2007-07
NCT00510705 TERMINATED
Severe Coronary Artery Disease; Obesity; Impaired Glucose Tolerance
University of Leipzig
 2007-07
NCT00951899 COMPLETED
Type 2 Diabetes
Mayo Clinic
 2009-08 PHASE4
NCT00951899 COMPLETED
Type 2 Diabetes
Mayo Clinic
 2009-08 PHASE4
NCT01693289 COMPLETED
Focus of Study
Zagazig University
 2012-01 PHASE1
NCT01693289 COMPLETED
Focus of Study
Zagazig University
 2012-01 PHASE1
NCT01011868 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2009-11 PHASE2
NCT01011868 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2009-11 PHASE2
NCT01243385 COMPLETED
Prostate Cancer
Swiss Cancer Institute
 2010-12-23 PHASE2
NCT01243385 COMPLETED
Prostate Cancer
Swiss Cancer Institute
 2010-12-23 PHASE2
NCT01210001 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2010-09 PHASE3
NCT01210001 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2010-09 PHASE3
NCT01338870 COMPLETED
Diabetes Mellitus, Type 2
Pfizer
 2011-06 PHASE2
NCT01137812 COMPLETED
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC
 2010-07 PHASE3
NCT01342744 UNKNOWN
Metabolic Syndrome
Mahidol University
 2011-04 PHASE4
NCT01338870 COMPLETED
Diabetes Mellitus, Type 2
Pfizer
 2011-06 PHASE2
NCT01137812 COMPLETED
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC
 2010-07 PHASE3
NCT01342744 UNKNOWN
Metabolic Syndrome
Mahidol University
 2011-04 PHASE4
NCT00451568 COMPLETED
Polycystic Ovary Syndrome
Odense University Hospital
 2007-03 PHASE4
NCT00838903 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2009-02 PHASE3
NCT01679574 COMPLETED
Polycystic Ovary Syndrome
Assiut University
 2009-01
NCT01509001 COMPLETED
Type 2 Diabetes
University of Sao Paulo
 2011-01 PHASE4
NCT01204294 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2010-09 PHASE3
NCT01463228 COMPLETED
Healthy
Janssen Research & Development, LLC
 2011-09 PHASE1
NCT00838903 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2009-02 PHASE3
NCT00451568 COMPLETED
Polycystic Ovary Syndrome
Odense University Hospital
 2007-03 PHASE4
NCT01679574 COMPLETED
Polycystic Ovary Syndrome
Assiut University
 2009-01
NCT01509001 COMPLETED
Type 2 Diabetes
University of Sao Paulo
 2011-01 PHASE4
NCT01204294 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2010-09 PHASE3
NCT01463228 COMPLETED
Healthy
Janssen Research & Development, LLC
 2011-09 PHASE1
NCT01289119 COMPLETED
Diabetes Mellitus, Type 2
Takeda
 2010-12 PHASE3
NCT01384279 COMPLETED
Obesity
Beitou Armed Forces Hospital, Taipei, Taiwan
 2011-05
NCT01444248 COMPLETED
Type 2 Diabetes Mellitus
Handok Inc.
 2010-08 PHASE4
NCT01169779 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2010-07 PHASE3
NCT01289119 COMPLETED
Diabetes Mellitus, Type 2
Takeda
 2010-12 PHASE3
NCT01384279 COMPLETED
Obesity
Beitou Armed Forces Hospital, Taipei, Taiwan
 2011-05
NCT01444248 COMPLETED
Type 2 Diabetes Mellitus
Handok Inc.
 2010-08 PHASE4
NCT01169779 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2010-07 PHASE3
NCT01135433 COMPLETED
Type 2 Diabetes Mellitus
Astellas Pharma Inc
 2010-05-15 PHASE3
NCT01135433 COMPLETED
Type 2 Diabetes Mellitus
Astellas Pharma Inc
 2010-05-15 PHASE3
NCT01365091 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2011-06 PHASE1
NCT01454622 COMPLETED
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
 2011-09 PHASE1
NCT01290575 COMPLETED
Type 2 Diabetes
Bristol-Myers Squibb
 2011-02 PHASE1
NCT00849056 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2009-01 PHASE3
NCT01349387 COMPLETED
Type 2 Diabetes
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
 2011-05
NCT01365091 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2011-06 PHASE1
NCT01454622 COMPLETED
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
 2011-09 PHASE1
NCT01290575 COMPLETED
Type 2 Diabetes
Bristol-Myers Squibb
 2011-02 PHASE1
NCT01349387 COMPLETED
Type 2 Diabetes
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
 2011-05
NCT00849056 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2009-01 PHASE3
NCT01478308 WITHDRAWN
Prostate Cancer
New Mexico Cancer Research Alliance
 2011-06 PHASE2
NCT00536211 WITHDRAWN
Metabolic Syndrome X; Insulin Resistance; Hypertension; Hypercholesterolemia; Obesity
University of Kansas Medical Center
 2009-06
NCT01478308 WITHDRAWN
Prostate Cancer
New Mexico Cancer Research Alliance
 2011-06 PHASE2
NCT00536211 WITHDRAWN
Metabolic Syndrome X; Insulin Resistance; Hypertension; Hypercholesterolemia; Obesity
University of Kansas Medical Center
 2009-06
NCT02972723 COMPLETED
Chronic Hepatitis C Infection
Nottingham University Hospitals NHS Trust
 2011-03 PHASE4
NCT01274130 COMPLETED
Healthy Adult
Yonsei University
 2010-12
NCT01274130 COMPLETED
Healthy Adult
Yonsei University
 2010-12
NCT02972723 COMPLETED
Chronic Hepatitis C Infection
Nottingham University Hospitals NHS Trust
 2011-03 PHASE4
NCT00720161 COMPLETED
Spina Bifida; Neuromuscular Diseases
Universitaire Ziekenhuizen KU Leuven
 2006-11
NCT00720161 COMPLETED
Spina Bifida; Neuromuscular Diseases
Universitaire Ziekenhuizen KU Leuven
 2006-11
NCT06326840 COMPLETED
Metabolic Disturbance; Hyperprolactinemia; Schizophrenia
Taipei Medical University Hospital
 2010-05-31
NCT06326840 COMPLETED
Metabolic Disturbance; Hyperprolactinemia; Schizophrenia
Taipei Medical University Hospital
 2010-05-31
NCT01245166 UNKNOWN
The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg; Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in; Subjects With Type 2 Diabetes Mellitus.
Lotus Pharmaceutical
 2010-11 PHASE3
NCT01128153 COMPLETED
Type 2 Diabetes
AstraZeneca
 2010-06 PHASE3
NCT01602003 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2009-12 PHASE3
NCT01245166 UNKNOWN
The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg; Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in; Subjects With Type 2 Diabetes Mellitus.
Lotus Pharmaceutical
 2010-11 PHASE3
NCT01602003 COMPLETED
Type 2 Diabetes Mellitus
LG Life Sciences
 2009-12 PHASE3
NCT01128153 COMPLETED
Type 2 Diabetes
AstraZeneca
 2010-06 PHASE3
NCT01521624 COMPLETED
Type 2 Diabetes Mellitus
Tehran University of Medical Sciences
 2010-10
NCT00976937 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2009-08 PHASE3
NCT00717457 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2008-07 PHASE3
NCT01521624 COMPLETED
Type 2 Diabetes Mellitus
Tehran University of Medical Sciences
 2010-10
NCT00976937 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2009-08 PHASE3
NCT00717457 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2008-07 PHASE3
NCT00763451 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2008-09 PHASE3
NCT01443221 COMPLETED
Healthy
JW Pharmaceutical
 2010-12 PHASE1
NCT01046422 COMPLETED
Diabetes Type 2
Bristol-Myers Squibb
 2010-05 PHASE2
NCT00713830 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2008-07 PHASE3
NCT00763451 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2008-09 PHASE3
NCT01443221 COMPLETED
Healthy
JW Pharmaceutical
 2010-12 PHASE1
NCT00713830 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2008-07 PHASE3
NCT01046422 COMPLETED
Diabetes Type 2
Bristol-Myers Squibb
 2010-05 PHASE2
NCT00775164 WITHDRAWN
Obesity; Insulin Resistance
University of Minnesota
 2009-01 PHASE4
NCT00775164 WITHDRAWN
Obesity; Insulin Resistance
University of Minnesota
 2009-01 PHASE4
NCT00885352 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2009-04-15 PHASE3
NCT00885352 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2009-04-15 PHASE3
NCT00722371 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-09-05 PHASE3
NCT00722371 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-09-05 PHASE3
NCT01034111 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2010-03-01 PHASE3
NCT01034111 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2010-03-01 PHASE3
NCT01105429 COMPLETED
Diabetes Mellitus, Non-Insulin-Dependent
Bristol-Myers Squibb
 2010-05 PHASE1
NCT01105429 COMPLETED
Diabetes Mellitus, Non-Insulin-Dependent
Bristol-Myers Squibb
 2010-05 PHASE1
NCT01012037 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2009-11 PHASE2
NCT01012037 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2009-11 PHASE2
NCT01009580 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-11-05 PHASE3
NCT01009580 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-11-05 PHASE3
NCT01171456 WITHDRAWN
Gestational Diabetes Mellitus
Intermountain Health Care, Inc.
 2010-04
NCT00770445 COMPLETED
Diabetes Mellitus
Takeda
 2008-05 PHASE4
NCT01171456 WITHDRAWN
Gestational Diabetes Mellitus
Intermountain Health Care, Inc.
 2010-04
NCT00770445 COMPLETED
Diabetes Mellitus
Takeda
 2008-05 PHASE4
NCT00909480 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-05 PHASE4
NCT00991055 UNKNOWN
Type 2 Diabetes
National Cheng-Kung University Hospital
 2008-05 PHASE4
NCT01029795 TERMINATED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2010-02 PHASE2
NCT00588172 WITHDRAWN
Type 2 Diabetes
Mayo Clinic
 2010-06 PHASE4
NCT00909480 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2009-05 PHASE4
NCT00991055 UNKNOWN
Type 2 Diabetes
National Cheng-Kung University Hospital
 2008-05 PHASE4
NCT01029795 TERMINATED
Diabetes Mellitus, Type 2
Eli Lilly and Company
 2010-02 PHASE2
NCT00588172 WITHDRAWN
Type 2 Diabetes
Mayo Clinic
 2010-06 PHASE4
NCT00924573 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2009-05 PHASE3
NCT00924573 COMPLETED
Type 2 Diabetes Mellitus
Sanofi
 2009-05 PHASE3
NCT00659568 COMPLETED
Breast Cancer; Endometrial Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
London Health Sciences Centre
 2008-03 PHASE1
NCT00659568 COMPLETED
Breast Cancer; Endometrial Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
London Health Sciences Centre
 2008-03 PHASE1
NCT00541450 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-01-15 PHASE3
NCT00541450 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-01-15 PHASE3
NCT00940472 COMPLETED
Diabetes Type 2
Laboratorios Silanes S.A. de C.V.
 2009-03 PHASE2; PHASE3
NCT00822211 COMPLETED
Type 2 Diabetes Mellitus
Novartis
 2008-12 PHASE3
NCT00940472 COMPLETED
Diabetes Type 2
Laboratorios Silanes S.A. de C.V.
 2009-03 PHASE2; PHASE3
NCT00822211 COMPLETED
Type 2 Diabetes Mellitus
Novartis
 2008-12 PHASE3
NCT00545584 COMPLETED
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC
 2007-04-01 PHASE3
NCT00545584 COMPLETED
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC
 2007-04-01 PHASE3
NCT00532935 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-01-26 PHASE3
NCT00532935 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2008-01-26 PHASE3
NCT00871936 COMPLETED
Type 2 Diabetes
Response Pharmaceuticals
 2009-04 PHASE2
NCT00832481 UNKNOWN
Type 2 Diabetes
Chinese PLA General Hospital
 2009-01
NCT00667732 COMPLETED
Type 2 Diabetes
Oregon Health and Science University
 2007-03 PHASE4
NCT00749190 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2008-08 PHASE2
NCT00871936 COMPLETED
Type 2 Diabetes
Response Pharmaceuticals
 2009-04 PHASE2
NCT00832481 UNKNOWN
Type 2 Diabetes
Chinese PLA General Hospital
 2009-01
NCT00667732 COMPLETED
Type 2 Diabetes
Oregon Health and Science University
 2007-03 PHASE4
NCT00749190 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2008-08 PHASE2
NCT00063635 COMPLETED
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 2005-09 PHASE3
NCT00814294 COMPLETED
Diabetes
Diasome Pharmaceuticals
 2008-12 PHASE2; PHASE3
NCT00420511 COMPLETED
Type 2 Diabetes Mellitus
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
 2007-01 PHASE2
NCT00802100 COMPLETED
Schizophrenia
National Institute of Mental Health (NIMH)
 2008-12 PHASE4
NCT00814294 COMPLETED
Diabetes
Diasome Pharmaceuticals
 2008-12 PHASE2; PHASE3
NCT00063635 COMPLETED
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 2005-09 PHASE3
NCT00420511 COMPLETED
Type 2 Diabetes Mellitus
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
 2007-01 PHASE2
NCT00802100 COMPLETED
Schizophrenia
National Institute of Mental Health (NIMH)
 2008-12 PHASE4
NCT00941382 UNKNOWN
Obesity
Laboratorios Silanes S.A. de C.V.
 2008-11 PHASE3
NCT00575588 COMPLETED
Type 2 Diabetes
AstraZeneca
 2007-12 PHASE3
NCT00159575 TERMINATED
Polycystic Ovary Syndrome
Norwegian University of Science and Technology
 2005-03 PHASE4
NCT00575588 COMPLETED
Type 2 Diabetes
AstraZeneca
 2007-12 PHASE3
NCT00941382 UNKNOWN
Obesity
Laboratorios Silanes S.A. de C.V.
 2008-11 PHASE3
NCT00159575 TERMINATED
Polycystic Ovary Syndrome
Norwegian University of Science and Technology
 2005-03 PHASE4
NCT00817778 COMPLETED
Type 2 Diabetes
AstraZeneca
 2009-01 PHASE2
NCT01228240 COMPLETED
Diabetes Mellitus, Type 2 AND Metformin
Zanjan University of Medical Sciences
 2008-12 PHASE4
NCT00817778 COMPLETED
Type 2 Diabetes
AstraZeneca
 2009-01 PHASE2
NCT01228240 COMPLETED
Diabetes Mellitus, Type 2 AND Metformin
Zanjan University of Medical Sciences
 2008-12 PHASE4
NCT00601250 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2008-01 PHASE3
NCT00601250 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2008-01 PHASE3
NCT01300637 UNKNOWN
Obesity; Metabolic Syndrome; Schizophrenia
Taipei Medical University WanFang Hospital
 2008-11
NCT00473876 COMPLETED
Congestive Heart Failure; Insulin Resistance
University of Dundee
 2007-08 PHASE4
NCT01300637 UNKNOWN
Obesity; Metabolic Syndrome; Schizophrenia
Taipei Medical University WanFang Hospital
 2008-11
NCT00473876 COMPLETED
Congestive Heart Failure; Insulin Resistance
University of Dundee
 2007-08 PHASE4
NCT00666458 COMPLETED
Type 2 Diabetes
AstraZeneca
 2008-04 PHASE3
NCT00666458 COMPLETED
Type 2 Diabetes
AstraZeneca
 2008-04 PHASE3
NCT00637273 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2008-01 PHASE3
NCT00614120 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-01 PHASE3
NCT00809536 TERMINATED
Generalized Anxiety Disorder
Pfizer
 2009-01 PHASE1
NCT00637273 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2008-01 PHASE3
NCT00614120 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-01 PHASE3
NCT00809536 TERMINATED
Generalized Anxiety Disorder
Pfizer
 2009-01 PHASE1
NCT00842140 COMPLETED
Polycystic Ovary Syndrome
University of Sao Paulo
 2006-02
NCT00842140 COMPLETED
Polycystic Ovary Syndrome
University of Sao Paulo
 2006-02
NCT00648869 WITHDRAWN
Healthy
Hadassah Medical Organization
 2008-06
NCT00648869 WITHDRAWN
Healthy
Hadassah Medical Organization
 2008-06
NCT00611884 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-01 PHASE2
NCT00611884 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2008-01 PHASE2
NCT00082381 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2003-06 PHASE3
NCT00082407 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2003-11 PHASE3
NCT00082381 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2003-06 PHASE3
NCT00082407 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2003-11 PHASE3
NCT00468039 COMPLETED
Diabetes Mellitus, Type 2
Novartis
 2007-03-06 PHASE3
NCT00468039 COMPLETED
Diabetes Mellitus, Type 2
Novartis
 2007-03-06 PHASE3
NCT00105066 COMPLETED
Obesity; Hypertension; Hypercholesterolemia; Hyperglycemia
National Institute on Aging (NIA)
 2004-01 PHASE2
NCT00105066 COMPLETED
Obesity; Hypertension; Hypercholesterolemia; Hyperglycemia
National Institute on Aging (NIA)
 2004-01 PHASE2
NCT00546741 COMPLETED
Healthy Male and Female Subjects
AstraZeneca
 2007-11 PHASE1
NCT00772174 COMPLETED
Diabetes Mellitus
Takeda
 2007-01 PHASE3
NCT00546741 COMPLETED
Healthy Male and Female Subjects
AstraZeneca
 2007-11 PHASE1
NCT00772174 COMPLETED
Diabetes Mellitus
Takeda
 2007-01 PHASE3
NCT00131664 COMPLETED
Type 2 Diabetes Mellitus
Canadian Heart Research Centre
 2005-09 PHASE3
NCT00131664 COMPLETED
Type 2 Diabetes Mellitus
Canadian Heart Research Centre
 2005-09 PHASE3
NCT00400231 COMPLETED
Metabolic Syndrome x
University of Pennsylvania
 2005-08 PHASE2
NCT00641407 COMPLETED
Type 2 Diabetes Mellitus; Hypoglycemia
University of Campania Luigi Vanvitelli
 2007-01 PHASE4
NCT00400231 COMPLETED
Metabolic Syndrome x
University of Pennsylvania
 2005-08 PHASE2
NCT00641407 COMPLETED
Type 2 Diabetes Mellitus; Hypoglycemia
University of Campania Luigi Vanvitelli
 2007-01 PHASE4
NCT00423501 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2007-02 PHASE2
NCT00399711 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-11 PHASE3
NCT00423501 COMPLETED
Diabetes Mellitus Type 2
Hoffmann-La Roche
 2007-02 PHASE2
NCT00399711 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-11 PHASE3
NCT00396227 COMPLETED
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals
 2006-10 PHASE3
NCT00295633 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2006-03 PHASE3
NCT00295633 COMPLETED
Diabetes Mellitus, Type 2
AstraZeneca
 2006-03 PHASE3
NCT00396227 COMPLETED
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals
 2006-10 PHASE3
NCT00328172 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2006-05 PHASE2
NCT00328172 COMPLETED
Diabetes Mellitus, Type 2
Boehringer Ingelheim
 2006-05 PHASE2
NCT00318461 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT00318461 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-05 PHASE3
NCT00376038 COMPLETED
Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 2
GlaxoSmithKline
 2006-08 PHASE1
NCT00376038 COMPLETED
Type 2 Diabetes Mellitus; Diabetes Mellitus, Type 2
GlaxoSmithKline
 2006-08 PHASE1
NCT01490658 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-06 PHASE1
NCT01490658 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2006-06 PHASE1
NCT00103857 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2005-03-17 PHASE3
NCT00103857 COMPLETED
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC
 2005-03-17 PHASE3
NCT00279045 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2000-01-03 PHASE3
NCT00279045 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2000-01-03 PHASE3
NCT00491725 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-09 PHASE4
NCT00491725 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2005-09 PHASE4
NCT00778466 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2006-02
NCT00778466 COMPLETED
Healthy
Ranbaxy Laboratories Limited
 2006-02
NCT00241605 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2003-06-25 PHASE4
NCT00961857 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2005-12-01 PHASE1
NCT00961857 COMPLETED
Type 2 Diabetes
Merck Sharp & Dohme LLC
 2005-12-01 PHASE1
NCT00241605 COMPLETED
Diabetes Mellitus, Type 2
GlaxoSmithKline
 2003-06-25 PHASE4
NCT00865033 COMPLETED
Type 2 Diabetes
Sandoz
 2005-11 PHASE1
NCT00086502 COMPLETED
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC
 2004-06 PHASE3
NCT00086502 COMPLETED
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC
 2004-06 PHASE3
NCT00865033 COMPLETED
Type 2 Diabetes
Sandoz
 2005-11 PHASE1
NCT00184626 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2004-09-10 PHASE4
NCT00184626 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2004-09-10 PHASE4
NCT00679679 COMPLETED
Polycystic Ovary Syndrome
Hospital Privado de Cordoba, Argentina
 2003-01 PHASE4
NCT00679679 COMPLETED
Polycystic Ovary Syndrome
Hospital Privado de Cordoba, Argentina
 2003-01 PHASE4
NCT00099866 COMPLETED
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals
 2004-01 PHASE3
NCT00097279 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2004-08 PHASE3
NCT00099619 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2004-09 PHASE3
NCT00099866 COMPLETED
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals
 2004-01 PHASE3
NCT00097279 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2004-08 PHASE3
NCT00099619 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2004-09 PHASE3
NCT01465152 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-03-06 PHASE4
NCT01465152 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-03-06 PHASE4
NCT00703755 COMPLETED
Patients With Metabolic Syndrome
Solvay Pharmaceuticals
 2003-03 PHASE2
NCT00703755 COMPLETED
Patients With Metabolic Syndrome
Solvay Pharmaceuticals
 2003-03 PHASE2
NCT00865436 COMPLETED
Healthy
Actavis Inc.
 2004-04 PHASE1
NCT00865436 COMPLETED
Healthy
Actavis Inc.
 2004-04 PHASE1
NCT00865748 COMPLETED
Healthy
Actavis Inc.
 2004-01 PHASE1
NCT00865748 COMPLETED
Healthy
Actavis Inc.
 2004-01 PHASE1
NCT00834743 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-08 PHASE1
NCT00865852 COMPLETED
Healthy
Actavis Inc.
 2003-08 PHASE1
NCT00865072 COMPLETED
Healthy
Actavis Inc.
 2003-08 PHASE1
NCT00834743 COMPLETED
Healthy
Teva Pharmaceuticals USA
 2003-08 PHASE1
NCT00865852 COMPLETED
Healthy
Actavis Inc.
 2003-08 PHASE1
NCT00865072 COMPLETED
Healthy
Actavis Inc.
 2003-08 PHASE1
NCT01511172 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-08 PHASE2
NCT01511172 COMPLETED
Diabetes; Diabetes Mellitus, Type 2
Novo Nordisk A/S
 2002-08 PHASE2
NCT00944177 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00118950 COMPLETED
Diabetes Mellitus, Type 2
Steno Diabetes Center Copenhagen
 2001-03 PHASE4
NCT00396513 UNKNOWN
Polycystic Ovary Syndrome
Poznan University of Medical Sciences
 2005-09
NCT00384215 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2001-12 PHASE4
NCT00247117 UNKNOWN
Liver Diseases
Kaplan Medical Center
 2004-01
NCT00546442 COMPLETED
Chronic Hepatitis C
Valme University Hospital
 2006-05 PHASE4
NCT01006590 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2009-10 PHASE4
NCT01084486 COMPLETED
Nonalcoholic Fatty Liver Disease
Wolfson Medical Center
 PHASE1; PHASE2
NCT00464594 UNKNOWN
Diabetes Mellitus
Japan Early Diabetes Intervention Study Group
 2007-04
NCT00944177 COMPLETED
Healthy
Torrent Pharmaceuticals Limited
 PHASE1
NCT00349635 COMPLETED
Obesity
Solvay Pharmaceuticals
 2004-10 PHASE2
NCT00384215 COMPLETED
Diabetes Mellitus, Type 2
Sanofi
 2001-12 PHASE4
NCT00546442 COMPLETED
Chronic Hepatitis C
Valme University Hospital
 2006-05 PHASE4
NCT00118950 COMPLETED
Diabetes Mellitus, Type 2
Steno Diabetes Center Copenhagen
 2001-03 PHASE4
NCT00396513 UNKNOWN
Polycystic Ovary Syndrome
Poznan University of Medical Sciences
 2005-09
NCT00247117 UNKNOWN
Liver Diseases
Kaplan Medical Center
 2004-01
NCT01006590 COMPLETED
Type 2 Diabetes Mellitus
AstraZeneca
 2009-10 PHASE4
NCT01084486 COMPLETED
Nonalcoholic Fatty Liver Disease
Wolfson Medical Center
 PHASE1; PHASE2
NCT00464594 UNKNOWN
Diabetes Mellitus
Japan Early Diabetes Intervention Study Group
 2007-04
NCT00349635 COMPLETED
Obesity
Solvay Pharmaceuticals
 2004-10 PHASE2

(data from https://clinicaltrials.gov, updated on 2026-07-23)

Check the Metformin (1,1-Dimethylbiguanide) product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Metformin activates hepatic AMP-activated protein kinase, leading to downstream modulation of cellular metabolic pathways and the activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling. This pathway cascade reduces hepatic glucose production and promotes cellular homeostasis, contributing directly to improved glycemic regulation and therapeutic efficacy in clinical conditions including type 2 diabetes, polycystic ovary syndrome, and gestational diabetes.

Appendix RUO and cGMP Quality Standards

Quality Dimension RUO (Research Use Only) cGMP (Current Good Manufacturing Practice)
Clinical Applicability Prohibited in human clinical trials or medical diagnostics. Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status Non-regulated grade; exempt from drug manufacturing laws. Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment Unclassified analytical or research laboratories. Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control Basic purity and activity testing. Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation Basic equipment calibration; no process validation required. Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance Vendor self-declared without required formal QMS. Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact High risk of IND rejection if used as a critical raw material. Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).

Jump to

Note: Technical data last updated: Sep 1, 2026.